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ABSTRACT 
 
 The neural gut-brain axis is an important bidirectional pathway through which the gastrointestinal 
(GI) tract communicates with the central nervous system (CNS). This axis includes sensory nerves that 
send information from the GI tract to the brain and motor nerves that transmit descending information 
from the brain to the GI tract. Traditional research has focused on nutrient-induced changes in sensory 
neural signaling and the subsequent motor response altering muscular and secretory functions. These 
nerves, though, may also play novel, non-traditional roles in the function of the gut-brain axis. Just as 
nutrients have been shown to induce neuroplasticity of CNS neurons, long-term alterations in nutrition 
may do more than just change signaling, and ultimately lead to modifications in fiber density, branching, 
and terminal morphology. These neuroplastic changes may underlie aberrant signaling and could be 
associated with GI diseases, as has been found with CNS-associated neuroplasticity and disease. The GI 
tract also has to perform many functions beyond muscular contraction/relaxation and secretion. One 
essential function in maintaining GI homeostasis is the constant renewal of the cells lost due to normal 
apoptosis, a process whereby entire GI tissues can be replaced every few days. Because loss of the motor 
nerves of the gut-brain axis results in changes in the rate of tissue renewal and the location of the nerves 
are in close contact with the GI stem cells responsible for cell renewal, these motor nerves may play a 
direct role in inducing proliferation and differentiation of the GI tissue. I hypothesized that there are 
indeed new, non-traditional roles of the sensory and motor nerves of the gut-brain axis in neuroplasticity 
and tissue regeneration and tested the mechanisms underlying these processes. Specifically, I used rodents 
and swine mammalian models to develop new methods by which to investigate multiple hypotheses about 
nutrient-induced vagal sensory neuroplasticity and found a direct mechanism by which the autonomic 
motor nerves induce changes in intestinal epithelial renewal. The results of the experiments included in 
this dissertation establish roles for the neural gut-brain axis that are outside those that are traditionally 
studied, which can expand the available methods to manipulate gut-brain system for therapeutic purposes. 
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CHAPTER 1: LITERATURE REVIEW 
 
1.1 The gut-brain axis 
The neural gut-brain axis allows for bidirectional communication between the gastrointestinal 
(GI) tract and the brain (Fig. 1). Sensory information from the gastrointestinal tract to the brain is 
communicated through afferent fibers. These 
afferent fibers travel in two distinct pathways: 
the vagal afferent pathway (with fibers in the 
vagus nerve, or cranial nerve X), and the spinal 
afferent pathway (with fibers in spinal afferent 
nerves). These sensory pathways allow the 
central nervous system (CNS) to monitor GI 
function and integrate GI sensory information 
with the sensory information from other 
peripheral organs. In turn, motor signals are sent 
from the brain to the GI tract via efferent nerves 
that are sympathetic (SNS) and parasympathetic 
(PNS) fibers of the autonomic nervous system 
(ANS). The SNS fibers travel in thoracolumbar nerve tracts, while PNS fibers travel in craniosacral nerve 
tracts. Together, these SNS and PNS efferent fibers are responsible for effecting changes in GI function. 
Overall, the gut-brain axis provides a critical link for information to be exchanged between the CNS and 
the GI tract.  
1.2 The small intestine  
Among the GI organs that receive gut-brain neural innervation is the small intestine. The sensory 
and motor nerves of the gut-brain axis facilitate the main functions of the small intestine, including 
Figure 1. Sensory and motor pathways of the neural gut-brain axis. 
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digestion, propulsion, and absorption of all macronutrients. These nerves innervate the three distinct 
segments (i.e., duodenum, jejunum, and the ileum) and all but the outer serosal layer of the small intestine 
(i.e., mucosa, submucosa, muscularis externa; Brookes et al., 2013). The anatomy and traditional 
functional roles of the these sensory and motor nerves have largely been identified and found to 
coordinate the actions of the small intestine along its axis and between other physiological systems of the 
body (i.e., cardiovascular, respiratory).  
1.3 Vagal afferent innervation of the small intestine 
 Vagal afferent terminals sense stimuli in the small intestine and transmit this sensory information 
to the CNS (Fig. 2). Nerve fibers travel in the vagus nerve (cranial nerve X), and neuronal cell bodies of 
these vagal afferent fibers are located in the nodose ganglia at the level of the superior cervical spinal 
cord. From the nodose ganglia, vagal afferent fibers project centrally toward the caudal brainstem, where 
they make synaptic connections with neurons in the nucleus of the solitary tract (NTS). The NTS is a 
major sensory integration center, receiving neural signals from many peripheral organs and bloodborne 
information. The NTS makes synaptic projections with a variety of other central nuclei (e.g., the dorsal 
motor nucleus of the vagus, the rostroventrolateral medulla, and the paraventricular nucleus of the 
hypothalamus). It is through this pathway that intestinal stimuli is able to be transmitted to the brain and 
integrated with other visceral/peripheral sensory information and forebrain circuits (Berthoud & 
Neuhuber, 2000).  
 The vagal afferent pathway transmits diverse sensory information. This vagal multimodality is 
achieved through the expression of several different types of receptors on vagal afferent terminals. In the 
small intestine, these receptors include two specialized types of mechanoreceptors, intraganglionic 
laminar endings (IGLEs) and intramuscular arrays (IMAs). In addition, a set of vagal afferent terminals 
within the mucosal layer of the intestine, termed mucosal afferents, sense chemosensory and possibly 
mechanosensory information within the intestinal mucosa. 
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Figure 2. Vagal afferent innervation of the small intestine. A. Representation of vagal afferent fibers from the intestinal tract to 
the brain, with the cell bodies of these nerves located in the nodose ganglia (NG) at the level of the superior cervical spinal cord 
(only one of the bilateral ganglia is depicted). B. Depiction of the three types of vagal afferent terminals and their location of 
innervation within specific layers of  the small intestine. Intraganglionic laminar endings (IGLEs) innervate the myenteric plexus 
(MP), located between the longitudinal muscle and circular muscle layers of the muscularis externa. Intramuscular arrays (IMAs) 
innervate muscle fibers of the longitudinal and circular muscle layers. Mucosal afferents innervate intestinal epithelial crypts and 
villi in the mucosa. The nerve fibers of all terminal types collectively travel in the vagus nerve. The nodose ganglion houses the 
vagal afferent neuron cell bodies. Vagal afferent fibers synapse within the nucleus of the solitary tract (NTS) in the caudal 
brainstem.   
 Intraganglionic laminar endings (IGLEs), are mechanosensitive vagal afferent terminals found 
throughout the small intestine (Berthoud et al., 1997; Fox et al., 2000; Phillips & Powley, 2000; Wang & 
Powley, 2000). These mechanoreceptors are located in between the two smooth muscle layers of the 
muscularis externa, which includes the circular and the longitudinal muscle layers. IGLEs make contact 
with the myenteric plexus of the enteric nervous system, which is the intrinsic neural network of the GI 
tract. Functionally, IGLEs have been hypothesized to monitor mechanical movement involved in the 
contraction of the smooth muscle layers of the small intestine (Powley & Phillips, 2002). Although this 
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has not been definitively proven in the small intestine, IGLEs have been shown to be 
electrophysiologically responsive to distension in the stomach (Zagorodnyuk et al., 2001), which supports 
the hypothesis that they are involved in sensing mechanical movement. 
Intramuscular arrays (IMAs) are a type of mechanosensitive vagal afferent mechanoreceptors that 
directly innervate the circular and longitudinal muscle layers of the small intestine. (Fox et al., 2000; 
Phillips & Powley, 2000; Powley & Phillips, 2002). IMA arborizations produce the elongated, narrow 
array of nerve terminals that run parallel to and eventually make contact with smooth muscle fibers (Fox 
et al., 2000; Wang & Powley, 2000). IMAs are distributed sparsely throughout most of the small 
intestine, but are found in very high densities in sphincter regions including the pyloric sphincter (located 
between the stomach and small intestine) and the ileocecal valve (located between the ileum and the 
cecum; the Fox et al., 2000; Wang & Powley, 2000). Sphincter IMAs are hypothesized to sense stretch 
based on their dense localization in areas of the stomach that stretch to accommodate meals, but 
functional studies investigating this have not been performed (Powley & Phillips, 2002; Powley et al., 
2011; Powley et al., 2014). In the small intestine, putative stretch signals from IMAs may participate in 
coordinating sphincter function, allowing food to enter into the next segment of the GI tract and 
subsequently preventing reflux back into the previous segment (Powley & Phillips, 2002).  
Mucosal afferent terminals are free nerve endings that innervate the mucosa (Berthoud et al., 
1995; Powley et al., 2011). Throughout the small intestine, mucosal afferent terminals come into close 
contact with the basal side of intestinal epithelial cells of both the villi and crypts (Powley et al., 2011). 
The populations of villus and crypt afferents are morphologically distinct, with separate nerves 
innervating each of these regions. It is important to note that these mucosal afferents do not make direct 
contact with the lumen of the small intestine (Powley et al., 2011). Functionally, mucosal afferents have 
been determined to be chemosensitive and mechanosensitive (Powley et al., 2011). Both direct and 
indirect mechanisms occur for vagal afferents to sense nutrients and send this information to the brain. 
Direct sensing of absorbed nutrients by vagal afferents has been recently established, specifically 
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regarding fatty acids (de Lartigue & Diepenbroek, 2016). Vagal afferent neurons express fatty acid 
receptors, including fatty acid receptor G-protein coupled receptor 40 (Darling et al., 2014) and 
peroxisome proliferator-activated receptor γ (Liu et al., 2014a). Fatty acids can act directly on vagal 
afferent neurons in vitro, as demonstrated by changes in cytosolic calcium concentrations (Darling et al., 
2014). This functional evidence and the position of these nerves in close contact with the nutrients 
absorbed from the intestine makes it likely that they are sensing macronutrients directly, including but not 
necessarily limited to fatty acids. In addition to sensing nutrients directly, it is well established that vagal 
afferent fibers sense nutrients indirectly by responding to factors released by epithelial cells in response to 
nutrients. Specifically, satiety peptides (e.g., cholecystokinin, glucagon-like peptide 1, peptide YY) are 
released by enteroendocrine cells in response to macronutrients in the intestinal lumen. The level of 
release may vary with the level and type of specific macronutrients present. Thus, type and amount of 
macronutrients in the intestinal lumen are sensed indirectly by mucosal vagal afferents (Dockray, 2014). 
Vagal afferent fibers in the small intestinal mucosa also respond electrophysiologically to mechanical 
stimulation, the physiological function of which is not entirely clear (Clarke & Davison, 1978). However, 
it has been postulated that these rapidly adapting mechanoreceptors sense the perturbations of the villi as 
a bolus of food passes down the intestinal tract (Powley et al., 2011). Overall, these terminals are indeed 
providing critical sensory information about the small intestinal mucosa to the brain, but the available 
technology is insufficient to answer many of the specific questions about what and how these afferents are 
signaling.  
1.4 Functional roles of the sensory branch of the gut-brain axis  
Traditionally-defined roles of the sensory gut-brain axis 
  As described above, sensory pathways send information about GI status so that this information 
can be used to regulate functions of the GI tract and coordinate this activity with other physiological 
systems in the body. With respect to sensory pathways, previous research has focused on the how these 
nerves send signals about food intake from the gut to the brain. These nerves have been shown to detect 
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amount and type of food in the GI tract (Raybould, 2010; Dockray, 2014; de Lartigue & Diepenbroek, 
2016). Consequently, these nerves play a crucial role in satiety signaling (Powley & Phillips, 2004; 
Berthoud, 2008), and it has been hypothesized that dysregulation in this signaling contributes to the 
development of obesity (de Lartigue, 2016). In addition, a great deal of research has investigated how 
sensory nerves transmit pain signals from the GI tract, which are thought to contribute to visceral pain in 
disease states (Grundy, 2002; Christianson & Davis, 2010).  
Non-traditional role of the sensory gut-brain axis: Neuroplasticity in aberrant sensory gut-brain 
signaling 
 Neuroplasticity is an important adaptive process of the nervous system, and refers to changes in 
neurons including neuronal excitability, levels of signaling molecules, and/or morphology.  
Neuroplasticity occurs not only in the CNS, but also in peripheral nerves. Neuroplastic changes of the 
vagal afferent sensory nerves are of particular interest due to the association of these changes in these 
nerves with diseases such as obesity and inflammatory bowel disease. On a molecular level, these 
diseases are associated with environmental changes within the gut (e.g., dietary, inflammatory), which 
drive neuroplastic alterations in the level or function of protein-kinase and metabolic signaling molecules.  
Ultimately, these changes lead to aberrant sensory signaling in the gut-brain axis. Another consequence of 
these disease-associated neuroplastic changes in signaling molecules is the initiation of morphological 
neuroplastic changes. Morphological neuroplasticity includes changes in fiber density, branching, and 
terminal morphology of neurons, all of which have been demonstrated in vagal afferent nerves under 
different disease conditions (Phillips & Powley, 2001; Phillips et al., 2010; Brierley & Linden, 2014; Sen 
et al., 2017; de Lartigue & Xu, 2018). These morphological neuroplastic changes can ultimately affect 
neuronal signaling and the ability of the neuron to properly transmit sensory stimuli from the gut to the 
brain, providing an additional route by which a dysregulation of gut-brain signaling can occur.	Although 
it is known that molecular neuroplastic changes occur in vagal afferent neurons in obesity (de Lartigue, 
2016), it is not known if the aberrant gut-brain signaling in obesity is also associated with morphological 
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neuroplastic changes. Thus, I set out to test whether morphological neuroplastic changes occur in obesity, 
and to investigate the mechanisms associated with these putative morphological neuroplastic changes. 
Investigation of these changes and their underlying mechanisms may lead to the development of 
treatments that reverse neuroplastic changes driving aberrant gut-brain signaling in obesity.  
1.5 Motor innervation of the small intestine 
The autonomic nervous system 
Motor innervation of the gut-brain axis is a part of the autonomic nervous system (ANS). The 
ANS is the division of the peripheral nervous system that controls unconscious functions of the internal 
organs. The ANS can react quickly to changes in the environment or body state, altering the functions of 
peripheral organs. The ANS is divided into two branches, the sympathetic nervous system (SNS) and the 
parasympathetic nervous system (PNS). The SNS controls the ‘fight or flight’ response, meaning that 
when the SNS is activated, it prepares the body to confront or escape a predator or other threat. In the 
small intestine, SNS activation inhibits digestive function, as digestion is not a critical function to 
promote during a threat (McCorry, 2007). In contrast, the PNS functions to conserve and restore energy to 
the body while directing necessary ‘housekeeping’ processes such as waste elimination. Therefore, the 
PNS is colloquially referred to as the ‘rest and digest’ branch of the ANS. In the small intestine, PNS 
activation stimulates digestive functions (McCorry, 2007). The activity of the SNS and PNS are in 
constant balance, working together to determine the appropriate responses of organs under different 
circumstances. These ‘fight or flight’ and ‘rest and digest’ scenarios are classic examples of SNS and 
PNS dominance, respectively. However, both systems are constantly active at a basal level to maintain 
homeostasis (Wehrwein et al., 2016). 
SNS and PNS nerve pathways share a common organizational structure. Distinct SNS and PNS 
pathways project from the CNS to their respective target organs in a two-neuron pathway. The cell bodies 
of the preganglionic neurons, the first neuron in this pathway, originate in the CNS (autonomic nuclei in 
the brainstem or spinal cord) and project to a peripheral ganglion. In the ganglion, these preganglionic 
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neurons synapse onto the postganglionic neuron. The postganglionic neurons, the second neuron in this 
pathway, then synapse onto the cells within the target organs (Wehrwein et al., 2016). Higher-order 
control of this SNS and PNS outflow is enacted by preautonomic nuclei that make direct synaptic 
connections with preganglionic autonomic neurons in the brainstem or spinal cord (Browning & Travagli, 
2014). Through these pathways, the CNS can appropriately influence the function of the small intestine 
under a variety of environmental conditions. 
General organization of the sympathetic nervous system 
 The sympathetic nerve tracts are thoracolumbar, meaning that they originate from the thoracic 
region of the spinal column, spanning the first thoracic nerve root (T1) through the third lumbar nerve 
root (L3). Within the spinal cord, the majority of the cell bodies for the sympathetic preganglionic 
neurons are located in the intermediolateral cell column, or the IML. From the spinal cord, preganglionic 
SNS neurons project to either paravertebral ganglia within the sympathetic chain, or prevertebral ganglia 
that are located outside the sympathetic chain closer to the target organ. Within their respective ganglia, 
the preganglionic SNS neurons synapse onto postganglionic SNS neurons using acetylcholine (ACh) as a 
neurotransmitter. Finally, these postganglionic SNS neurons project to their respective target organs and 
make synaptic connections with target cells using norepinephrine (NE) as the main neurotransmitter. This 
neural pathway supplies the anatomy for the SNS to influence organ physiology and function.  
Sympathetic innervation of the small intestine 
 The sympathetic efferent pathways directly innervate target tissues within the small intestine (Fig. 
3), including cells within the circular muscle, the myenteric plexus, the submucosal plexus, the intestinal 
blood vessels, and the mucosa. Nearly all of the preganglionic SNS neurons that send signals to the small 
intestine pass through the sympathetic chain, traveling via the splanchnic nerves to synapse onto 
postganglionic SNS neurons within the in the prevertebral ganglia, specifically the celiac and mesenteric 
ganglia. The only exception is sympathetic innervation to blood vessels, which is supplied by neurons that 
synapse within the paravertebral ganglia of the sympathetic chain and then travel via spinal nerves to 
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innervate intestinal blood vessels. For all other targets, postganglionic PNS neurons project from the 
celiac or mesenteric ganglia project to both neuronal and non-neuronal targets within the small intestine. 
Neuronal targets include neurons of the enteric 
nervous system. Postganglionic SNS neurons make 
synaptic connections with enteric nervous system 
neurons located in the myenteric plexus or the 
submucosal plexus. The myenteric plexus is found 
in between the circular and longitudinal muscle 
layers, and sympathetic fibers innervating enteric 
neurons the myenteric plexus facilitate the inhibition 
of intestinal muscle movement. The submucosal 
plexus is located in the submucosal layer, and 
sympathetic fibers innervating enteric neurons in this 
plexus inhibit secretory function (Lomax et al., 
2010). Non-neuronal targets of sympathetic 
postganglionic neurons include the circular muscle 
layer at sphincter regions, which control muscle 
contractions (Lomax et al., 2010). Sympathetic fibers 
also come into close contact with epithelial cells in the 
mucosal layer. In particular, a thick net of nerve fibers 
are located at the base of the crypts where the stem 
cells reside (Gabella & Costa, 1968). Sympathetic 
nerve fibers in close approximation of the intestinal epithelium control electrolyte transport (Greenwood 
et al., 1987). Together, these nerves participate in controlling the diverse functions of the small intestine. 
 
Figure 3. Sympathetic innervation of the small intestine. 
Preganglionic sympathetic (SNS) neurons originate in the 
spinal cord. These neurons pass through the sympathetic 
chain and project via splanchnic nerves to the paravertebral 
ganglia, either the celiac ganglion or superior mesenteric 
ganglion. Within the ganglia, preganglionic SNS neurons 
make synaptic connections with postganglionic SNS 
neurons which project to target cells in the small intestine. 
These targets include cells in the myenteric plexus, the 
circular muscle, the submucosal plexus, and the mucosa, 
with particularly dense innervation of intestinal epithelial 
crypts in the mucosa.  Innervation of intestinal blood 
vessels is supplied by neurons that synapse in the 
sympathetic chain (not shown). (Abbreviations in figure: 
CG = celiac ganglion; SMG: superior mesenteric ganglion; 
LM = longitudinal muscle; MP = myenteric plexus; CM = 
circular muscle; SM = submucosa; M = mucosa.) 
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General organization of the parasympathetic nervous system 
 The preganglionic neurons of the PNS originate in the cranial and sacral regions of the CNS. The 
projections that originate in the brain travel to their 
respective target organs in the head, neck, thorax, and 
abdomen via cranial nerves. In contrast, the projections 
that originate in the sacral region of the spinal cord travel 
in spinal nerves to their target organs within the pelvis. 
Once reaching their target organs, the preganglionic PNS 
neurons make synaptic contact with postganglionic PNS 
neurons within parasympathetic ganglia, which are located 
in or near the target organs, using ACh as the main 
neurotransmitter. From the ganglia, the postganglionic 
neurons project a short distance to target cells, where they 
use ACh as the main neurotransmitter to effect target cells. 
Together, the cranial and sacral pathways allow control of 
peripheral function by the PNS.  
Parasympathetic innervation of the small intestine 
 Parasympathetic innervation of the small intestine 
(Fig. 4) is provided through the cranial pathway, 
specifically through the vagus nerve (cranial nerve X). 
Once reaching the small intestine, the vagal efferent fibers 
enter the parasympathetic ganglia, which are found in two 
ganglionated enteric plexuses: the myenteric plexus, 
between the circular and longitudinal muscle layers, and 
the submucosal plexus, located in the submucosa as the 
Figure 4. Parasympathetic innervation of the small 
intestine. Preganglionic parasympathetic (PNS) neurons 
that project to the small intestine originate in the dorsal 
motor nucleus of the vagus in the brainstem. These 
neurons project to the small intestine via the vagus 
nerve. These preganglionic neurons synapse onto 
postganglionic PNS neurons within the myenteric plexus 
or the submucosal plexus. From the myenteric plexus, 
postganglionic neurons synapse onto cells within the 
longitudinal or circular muscle layers.  From the 
submucosal plexus, postganglionic neurons synapse onto 
neurons within the mucosa, including both the crypts and 
villi. (Abbreviations in figure: DMV = dorsal motor 
nucleus of the vagus; LM = longitudinal muscle; MP = 
myenteric plexus; CM = circular muscle; SM = 
submucosa; M = mucosa.) 
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name implies (Holst et al., 1997; Chang et al., 2003). Within these plexuses, the preganglionic 
parasympathetic neurons make synaptic connections with postganglionic parasympathetic neurons. At 
this synapse, ACh is released from the presynaptic terminal of the postganglionic neuron and then binds 
to nAChRs on the postsynaptic terminal of the postganglionic neurons to effect downstream changes in 
postganglionic neurons (Albuquerque et al., 2009) (Fig 3). Unmyelinated postganglionic parasympathetic 
neurons then project from the myenteric plexus or submucosal plexus to target cells within the small 
intestine (Holst et al., 1997; Chang et al., 2003). It is important to note that postganglionic 
parasympathetic neurons are intermingled with enteric neurons that do not receive direct parasympathetic 
input (Powley, 2000). Postganglionic PNS neurons with cell bodies in the myenteric plexus project to 
longitudinal and circular muscle fibers to control smooth muscle movements of the GI tract (Nezami & 
Srinivasan, 2010). Postganglionic PNS neurons originating in the submucosal plexus project to the 
mucosa, terminating directly below intestinal epithelial crypts (Furness et al., 2014), and also have 
been shown to project to the villi (Chang et al., 2003). These neurons participate in regulating 
secretory function and hormone release from epithelial cells (Rocca & Brubaker, 1999; Chang et al., 
2003; Nezami & Srinivasan, 2010; Bohorquez et al., 2015). Ultimately, these PNS nerves coordinate 
small intestinal function under conditions of high PNS tone.  
1.6 Functional roles of the motor branch of the gut-brain axis  
Traditionally-defined roles of the motor gut-brain axis	 
 Like the sensory fibers, several topics have dominated investigation of the motor gut-brain axis 
functions. These have included control of motility, blood vessel regulation, secretion of hormones and 
electrolytes, and inflammation under homeostatic and disease conditions (Christensen, 1971; Taylor & 
Keely, 2007; Lomax et al., 2010; Cheng et al., 2013; Browning & Travagli, 2014; Bonaz et al., 2016). 
These studies have uncovered many capabilities of the motor gut-brain axis; however, there are additional 
functions of these efferent nerves to the gut that are becoming evident. 
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Non-traditional role of the motor gut-brain axis: Control of tissue regeneration 
Although the motor fibers of the gut-brain axis are known to modulate specific functions within 
the layers of the GI tract, they are also thought to play a role in the homeostatic regeneration of the tissue.  
Denervation (surgical or chemical) of either SNS or PNS nerves to the intestine alters intestinal epithelial 
crypt cell proliferation (Tutton & Helme, 1974; Musso et al., 1975a; Tsibulevskii & Orlova, 1976; Lachat 
& Goncalves, 1978; Kennedy et al., 1983; Callaghan, 1991). However, previous studies have not 
determined whether this effect is direct or indirect. Previous studies may have detected indirect effects on 
proliferation due to post denervation-induced changes in food intake, inflammation, or other factors that 
can alter intestinal epithelial cell proliferation (Dailey, 2014; Slater et al., 2017). In contrast, a direct 
effect could potentially be driven by autonomic neurotransmitters binding to receptors localized on 
proliferating cells of the intestinal epithelium. Furthermore, previous studies did not determine if these 
effects of denervation of PNS or SNS nerves on tissue regeneration persist long-term, which may lead to 
dysregulation of tissue size or function. Thus, I investigated if and how PNS or SNS motor nerves of the 
gut-brain axis could directly alter intestinal stem cell proliferation and evaluated the effect of loss of the 
motor nerves of the gut-brain axis in intestinal tissue regeneration in vivo. Together, these experiments 
begin to describe the molecular components and physiology through which a direct ANS control of stem 
cell proliferation and tissue regeneration may occur. This improved knowledge may lead to innovative 
treatments for tissue damage or dysfunction in the future.  
1.7 Summary 
 The sensory and motor connections between the small intestine and brain have the ability to sense 
a wide range of stimuli and subsequently coordinate appropriate responses. However, the full potential of 
this system has yet to be characterized. The following studies describe several lines of research pursuing 
improved understanding of non-traditional roles of the gut-brain axis innervation of the small intestine, 
which may uncover strategies to treat conditions that affect the gut-brain axis or its associated organs.  
Overall, I hypothesized that vagal afferent nerves undergo morphological neuroplastic changes in obesity, 
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and that the autonomic motor nerves of the gut-brain axis directly control intestinal epithelial stem cell 
proliferation.  Chapters two through five describe experiments in pursuit of these hypotheses. In chapter 
two, I developed methods to investigate vagal afferent nerve morphology and function in rats to allow 
improved techniques to study the effect of obesity on vagal afferent nerves. In chapter three, I used swine 
to evaluate the effect of obesity on neuron density, glial cell density, and neuroplasticity-associated 
proteins in the nodose ganglion. In chapter four, I isolated intestinal epithelial stem cells in mice to 
characterize their expression of autonomic neurotransmitter receptors, and determined the effect of the 
corresponding autonomic neurotransmitters on a proliferation-related gene in mouse-derived intestinal 
epithelial organoids. In chapter five, I evaluated the effect of autonomic neurotransmitters on proliferation 
in mouse-derived intestinal epithelial organoids. In chapter six, I used rats to determine the long-term 
effect of SNS or PNS nerve ablation on intestinal epithelial proliferation and apoptosis. In chapter seven, 
I summarize the significance of these results from these experiments and highlight further considerations 
for future research on these topics. Overall, this work adds to the knowledge base on the diverse roles of 
the neural gut-brain axis.  
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CHAPTER 2: PRACTICAL CONSIDERATIONS FOR EVALUATING VAGAL AFFERENT 
NEURONS 
 
(Modified from a publication submitted to Journal of Visualized Experiments) 
 
2.1 Introduction 
 The vagal afferent neurons are critical for the transmission of sensory afferent information from 
the periphery to the brain. The vagal afferents innervating the gastrointestinal (GI) tract have been widely 
studied in the control of food intake (Ritter et al., 2017), and are considered an important part of the gut 
brain axis. More recently, this field has expanded to include GI vagal afferent modulation of higher order 
cognitive processes, such as motivated approach and avoidance behaviors (Maniscalco & Rinaman, 2018) 
and declarative memory (Suarez et al., 2018). Thus, experimental methods to study vagal afferent neurons 
are of great interest to scientists in a diverse range of fields.  
 Vagal afferent cell bodies are located in the nodose ganglia, which are located bilaterally at the 
major bifurcation of the carotid artery. Experimental manipulation of this ganglion is a useful technique, 
but the surgical approach is deceptively difficult primarily due to the location of the nodose ganglion. 
Many delicate structures that require careful handling are encountered during the surgical approach. If 
damage to these structures is incurred during surgery, the animal’s post-surgical viability may be reduced. 
Thus, we describe in detail the approach to the nodose ganglia in rats, aiming to make this protocol more 
accessible to those who would like to embark on this technique for the first time. Standardization and 
improvement of this difficult technique throughout the scientific community can increase the post-
surgical viability of the animals and reduce post-surgical pain, improving overall experimental outcomes.  
 Once the surgical procedure is mastered, there are a variety of opportunities for further 
investigation of the vagal afferents nerves through the manipulation of this ganglion. These include 
intraganglionic nodose injections, tissue harvest for subsequent evaluation of gene and/or protein 
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expression, and cell culture protocols to grow nodose ganglion neurons in vitro. As a supplement to the 
surgical protocol, we describe the various techniques that may be used following the surgical approach to 
this ganglion. Ultimately, successful surgeries and effective use of the subsequent protocols described 
here can support research efforts to increase the overall understanding of the vagal afferent nerves. 
2.2 Protocol 
Ethics Statement 
Procedures involving animal subjects have been approved by the Institutional Animal Care and 
Use Committee at the University of Illinois at Urbana-Champaign. 
1) Pre-surgical procedures 
1.1) Initiate food deprivation (~12 h) at the end of the dark cycle prior to the surgery, even though rats do 
not normally eat at this time. The rats will undergo both surgical procedures near the end of the light 
cycle. This step is done to reduce anesthesia-induced nausea. 
1.2) Induce anesthesia in chamber with 5% isoflurane at 1.5L/min.  
CAUTION: Isoflurane is a potentially toxic anesthetic agent. Please refer to the SDS (Safety Data Sheet) 
for isoflurane to ensure proper administration of anesthesia for this procedure. 
1.2) Continue administration of 1.5-2% isoflurane through a nose cone at rate of 1.5L/min.  
1.3) Place the rat in a supine position, or dorsal recumbency, with the neck extended. Using surgical tape, 
tape down the arms, legs, and tail of the rat, taking care to minimize tension placed upon the limbs due to 
the tape restraints. Place a small amount of folded surgical gauze under the head of the rat in order to 
reduce pressure on the trachea.   
1.4) Clip the area from the rostral intermandibular space to the point of the shoulders with electric 
clippers to remove hair bilaterally to the base of the ear.  
1.5) Aseptically prepare the clipped area and surgical site by alternately wiping with povidone-iodine 
scrub and 70% isopropyl alcohol.  
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1.6) Provide physiologic monitoring of rats during anesthesia with an electrocardiogram and pulse 
oximetry. Place rats on a warming pad to maintain temperature. Monitor rectal temperature every 5 
minutes. Perform assessment of pain by toe pinch every 5 minutes. 
2) Dissection to the salivary gland and the linguofacial vein  
2.1) Using a #15 blade, incise the full thickness of the skin along the ventral midline from just rostral to 
the angle of the mandible to just cranial to the manubrium.  
2.2) Dissect the subcutaneous tissue along the same incision line with iris scissors. During this dissection, 
avoid causing damage to the mandibular salivary glands, which are lying on either side just deep to the 
incision.  
2.3) Carefully undermine the skin for approximately 1.5 cm bilaterally. Avoid causing damage to the 
blood vessels of the subdermal plexus in the skin.  
2.4) Identify the linguofacial vein running laterally to either mandibular salivary gland. The surgeon may 
operate the right or left side to identify the nodose ganglion, as the approach is the same.  
2.5) Carefully install blunt-tipped self-retaining retractors, retracting the skin bilaterally in order to 
improve visualization of the surgical field.  
3) Dissection to the intermuscular septum  
3.1) Lightly dissect the adipose and connective tissue lateral to the salivary gland and linguofacial vein 
using angled jeweler’s or other fine forceps and microvascular scissors.  
3.2) Carefully retract the mandibular salivary gland medially and cranially to allow identification of the 
intermuscular septum between the sternohyoideus and sternocephalicus muscles, lying deep to thin fascia. 
3.3) Dissect the thin fascia to allow access to the intermuscular septum. 
4) Dissection to the carotid artery 
4.1) Separate the muscles along the intermuscular septum for their length using a combination of blunt 
dissection with angled jeweler’s forceps and sharp dissection with microvascular scissors.  
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4.2) Retract the sternocephalicus muscle laterally, permitting identification of the omohyoideus muscle 
located deep to the sternohyoid and sternocephalicus muscles and slightly medial and cranial.  
4.3) Lightly dissect the axial line of the omohyoideus muscle to permit visualization of the carotid artery.  
5) Dissection to the nodose ganglion 
5.1) Lightly dissect the fascia surrounding the common carotid artery, extending in a cranial direction in 
order to locate its major bifurcation. 
5.2) Identify the vagus nerve and sympathetic nerve adjacent to the common carotid artery.  
5.3) Identify the nodose ganglion at the level of the major bifurcation in the carotid artery. The nodose 
ganglion can be identified as an ovoid structure ~3mm in diameter and light tan-grey in color, lying deep 
and axial to the branches of the common carotid artery. The branches of the common carotid artery 
include the internal carotid artery, occipital artery, and the cranial thyroid artery.  
5.4) Dissect the thin connective tissue overlying the nodose ganglion and around the carotid branches 
with an angled jeweler’s forceps to improve access to the nodose ganglion. 
6) Tracer injection (optional) 
Inject 2 uL of the tracer into the ganglion in the vicinity of the afferent cell bodies using a Hamilton 
syringe. Since the nodose is heavily encapsulated, it is practical to inject the appropriate tracer into the 
ganglion without significant leakage. Fast Green (F7252-5G, Sigma Aldrich) may be added to the tracer 
to visualize the tracer solution during injection.  
7) Wound closure  
7.1) Release retractors from the sternocephalicus muscle.  
7.2) Close the sternohyoid and sternocephalicus muscles using continuous suture pattern of 5-0 
polydioxanone or poliglecaprone 25.  
7.3) Release retractors from the skin.  
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7.4) Close the subcutaneous tissues using a continuous pattern of 6-0 polydioxanone or poliglecaprone 
25. Apply ethyl-cyanoacrylate skin glue topically to the skin edges while approximating the skin edges 
gently with forceps. 
7.5) Gently cleanse the incision of blood using sterile saline and gauze. 
8) Post-operative care 
8.1) Post-operatively after the tracer injection surgery, administer 0.02 mg/kg buprenorphine 
subcutaneously. (This dose will be repeated 12 hours following surgery.)  
8.2) Recover the animals in a clean, dry, single cage with warming pad with frequent observation by 
trained personnel.  
8.2.1) Give particular attention to thermoregulation, monitoring of heart rate, respiratory rate and 
respiratory effort, and management of postoperative pain or discomfort.  
8.2.2) Assess pain and level of consciousness by toe-pinch every 5 minutes. 
8.3) Once the animal is freely moving after recovery from anesthesia, place the animal back in their home 
cage with free access to food and water or return the animal to group housing.  
8.4) Monitoring can be less intense but should include attention to basic biologic functions of food intake 
and urine and feces elimination and to behavioral signs of post-operative pain including haunching, 
immobility anorexia, and lethargy.  
8.5) Twelve hours post-operatively after the tracer injection surgery, administer 0.02 mg/kg 
buprenorphine subcutaneously.  
8.6) Monitor the surgical site twice daily for postsurgical infections and signs of dehiscence. 
9) Critical steps within the protocol 
9.1) Surgeons must avoid damage to the salivary glands of the rat due to improper handling. Damage to 
the salivary glands may cause an inability to produce saliva post-operatively, which will severely 
compromise ingestive function. Damage to the salivary glands can be avoided by gently and completely 
removing connective tissue around the perimeter of the gland, eventually allowing the gland to ‘flip up’ 
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without tearing the gland. Then, blunt retractors must be used to lightly retract the gland away from the 
surgical field of view. Retraction using sharp retractors or applied with too much force will damage the 
salivary glands.  
9.2) The carotid artery is another structure that should be handled with extra caution. The nodose 
ganglion’s close proximity to the carotid artery necessitates the thorough dissection of the connective 
tissue surrounding carotid to expose the ganglion, especially since the ganglion lies deep to the carotid. It 
is recommended that after the clearing away of these connective tissues, the carotid is gently moved in the 
attempt to better visualize the ganglion. However, a common mistake is grabbing the artery by the full 
thickness. In order to prevent damage to the artery and possible thrombotic events, the artery must be 
gently moved by carefully by grasping onto the adventitia as opposed to grasping the full thickness of the 
artery.  
9.3) Another critical point of the protocol is the use of a proper dissection microscope, as it is crucial to 
the success of the surgery. It is not advisable to attempt this surgery using only the unaided eye, as this 
greatly increases the risk of damage to delicate structures as discussed above or incorrect execution of the 
injection of the neuroanatomical tracer.  
2.3 Discussion 
 The surgical approach to the nodose ganglion described above is a valuable experimental 
technique. This surgical method can be combined with other techniques to investigate the morphology 
and/or function of vagal afferent neurons. Scientists who have become proficient at this surgical approach 
have the option of performing neuroanatomical tracing of vagal afferents, regulating vagal afferent gene 
expression, selectively denervating vagal afferents originating in specific target tissues, or harvesting the 
nodose ganglion for evaluation of genes and proteins or culturing nodose ganglion neurons in vitro. Here, 
we briefly describe the available protocols to study vagal afferent neurons after successful surgical 
approach to the nodose ganglion.  
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 Monosynaptic neuronal tracers such as biotinylated dextran amines injected into the nodose 
ganglion are a useful option to label the vagal afferent nerves in vivo, including the ascending projections 
to the NTS (Shin et al., 2009) and descending projections to all innervated target organs, including the gut 
(Powley et al., 2011). Within the gut in particular, monosynaptic neuronal tracers are helpful to discern 
the vagal afferents from sensory neurons of the enteric nervous system or the spinal afferent neurons, and 
identify the structures with which they make synaptic connections (Powley et al., 2008). Morphological 
investigation of vagal afferent terminals can also provide insight into regeneration after injury (Phillips et 
al., 2000, 2003; Phillips & Powley, 2005; Powley et al., 2005), maladaptive neuroplasticity during aging 
(Phillips & Powley, 2001) or other neuroplastic changes within these nerves.  
 In addition to morphological evaluation, genetic manipulation of vagal afferent neurons can be 
achieved by intraganglionic injection protocols. Viral vectors injected into the nodose ganglion can 
conditionally knockdown or upregulate genes in vagal afferent neurons (Lai et al., 2003; Zhang et al., 
2014). This technique provides an opportunity for researchers to elucidate the function of different genes 
within the vagal afferent nerves in vivo.  
 Selective ablation of vagal afferent fibers can be achieved by injections of neurotoxins into the 
nodose ganglion. Specifically, the neurotoxin saporin conjugated to the GI peptide cholecystokinin 
(CCK) has been used to denervate GI vagal afferents only, while leaving vagal fibers that innervate other 
organs intact (Diepenbroek et al., 2017). When investigating GI vagal sensory function, this method is 
preferable compared with traditional techniques that are less selective in their denervation profile. 
Subdiaphragmatic vagotomy surgically eliminates all vagal sensory and motor fibers, which makes it 
impossible to discriminate the contributions of the sensory versus motor fibers in the effect being 
investigated (Davis et al., 2017). Selective deafferentation surgically eliminates just the vagal afferents, 
but encompasses vagal sensory projections to all innervated organs, not exclusively the GI tract (Sclafani 
et al., 2003). The neurotoxin capsaicin has been used in the past to selectively denervate vagal afferent C-
fibers, but there is evidence that this method destroys both motor and sensory C-fibers, and therefore is 
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not as selective as intended (Browning et al., 2013). Thus, the innovative CCK-SAP method to selectively 
ablate GI vagal afferents is a useful application of the surgical approach to the nodose ganglion, and can 
contribute greatly to the understanding of vagal afferent neurobiology.  
 The nodose ganglion can also be harvested during animal euthanization for electrophysiological 
analysis, analysis of genes or proteins, or cell culture. Specifically, whole cell patch clamp protocols have 
been developed to evaluate electrophysiological properties of nodose ganglia after they have been 
harvested (Li & Schild, 2002). Techniques can be applied to harvested nodose ganglia to investigate 
proteins and genes within the nodose. Nodose ganglion mmunohistochemistry has been used for 
localization of proteins, whereas Western blotting is used for quantification of protein levels (de La Serre 
et al., 2015). In addition, quantitative polymerase chain reaction (qPCR) and fluorescent in-situ 
hybridization can be used in the nodose ganglion to investigate gene expression or localization, 
respectively (Czyzyk-Krzeska et al., 1991; Zhuo & Helke, 1996; Page et al., 2007; Kentish et al., 2013). 
Although rat nodose ganglia contain a sufficient amount of tissue for these protocols, the ganglion is just 
3 mm in diameter. Therefore, nodose ganglia harvested from larger animals yield more tissue, affording 
the opportunity to evaluate more genes and proteins from the same animal. Finally, nodose ganglia can be 
harvested to perform primary cell culture in vitro. Traditional cell culture methods entail dissociation of 
the cells for subsequent growth (de Lartigue et al., 2007). Protocols have also been developed to grow the 
intact nodose ganglion in a 3D culture matrix, which are useful for evaluating axonal regeneration of 
ganglia in vitro (Lindsay & Rohrer, 1985; Wiklund & Ekstrom, 2000). Thus, the harvest of the nodose 
ganglion provides a variety of techniques to expand upon.  
 In summary, the surgical approach to the nodose ganglion can be a formidable task for those 
attempting the technique without guidance. However, proficiency can be achieved with the appropriate 
resources, after which there is a great deal opportunity for expansion upon this protocol. Proper 
application of this collection of methods can lead to further understanding of vagal morphology and 
function.  
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CHAPTER 3: EFFECT OF OBESITY ON THE NODOSE GANGLION IN SWINE 
3.1 Rationale 
 Due to the lack of data generated from methods developed in chapter 2, an alternative approach 
was used to study the effect obesity of the vagal afferent pathway in swine. We initiated a collaboration 
with a research group that routinely uses groups of obese and lean Ossabaw minipigs. A surgical 
approach to collect nodose ganglion tissue was developed, and tissues were collected from lean and obese 
animals. To determine the effect of obesity on cell number in the nodose ganglion, we measured neuron 
and glial cell density. We also investigated furin, a protein implicated in neuroplasticity, by measuring 
relative optical intensity of the furin protein after immunohistochemistry in the nodose ganglion. This 
pilot study will serve to inform our future research directions on the effect of obesity in the vagal afferent 
system.  
3.2 Materials and methods 
Animals  
 This protocol was approved by the Indiana University School of Medicine Animal Care and Use 
Committee and conducted in accordance with the “Guide for the Care and Use of Laboratory Animals”. 
For a total of 8 months, male Ossabaw miniature swine were fed either an excess-calorie, atherogenic diet 
(KT-324, Purina Test Diet; Purina, Richmond, IN) (n = 3) and consequently became obese, or a standard 
chow diet (n = 3) and remained lean. All pigs were individually housed with a 12-hour light/dark cycle 
and free access to drinking water.  
Tissue harvest  
 After conduction of the primary research project procedures under anesthesia, animals were 
euthanized by administration of sodium pentobarbital and subsequent removal of the heart. After 
collection of the carotid artery below the major bifurcation in the neck, the major bifurcation of the 
carotid artery was located and the right and left nodose ganglia were collected.  
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Tissue processing 
 Ganglia were were postfixed in 10% formalin for 24h at RT, then transferred to a 30% sucrose 
solution and stored at 4°C until sectioning. Ganglia were cut on a cryostat at 20 µm and mounted on 
Superfrost™ Plus Microscope Slides (Fisher Scientific, Pittsburgh, PA), with every fourth section 
mounted onto the same slide. 
Nissl staining and immunohistochemistry 
 Nissl staining on one set of slides was performed using a standard cresyl violet staining protocol 
to visualize neurons and glia. To visualize the furin protein in the nodose ganglia, immunohistochemistry 
with an anti-furin antibody was performed on another set of slides. Briefly, antigen retrieval was 
performed by immersing the slides in sodium citrate buffer (Sodium Citrate Hydrochloride, Fisher 
Scientific and Tween 20, Sigma- Aldrich, Germany, pH 6.0) for 20 min in a water bath at 95°C, then 
allowed to cool while still immersed in the sodium citrate buffer solution for 30 min at RT. Slides were 
rinsed between each step in 1X PBS. Slides were incubated in blocking solution containing 0.3% Triton-
X (Sigma-Aldrich, St. Louis, MO) and 3% Normal Donkey Serum (JacksonImmunoResearch, West 
Grove, PA) diluted in 1X PBS at RT for 1h. Sections were then incubated overnight in an anti-furin 
primary antibody (1:50, ab1831495, Abcam, San Francisco, CA) diluted in the blocking solution. 
Sections were incubated in a donkey anti-rabbit IgG H&L secondary antibody (1:500, ab6899, Abcam, 
San Francisco, CA) diluted in 1X PBS for 1h at RT. Sections were then incubated in an avidin–biotin 
complex (Vectastain Elite reagents, Vector Labs, Burlingame, CA) for 1h at RT. A diaminobenzidine-
hydrogen peroxidase reaction was performed using a substrate kit (SK-4100, Vector Laboratories, 
Burlingame, CA). Sections were left at an angle to dry overnight and then dehydrated in a series of graded 
ethanols followed by xylenes. Slides were coverslipped with Permount mounting media (Fisher 
Scientific, Fair Lawn, NJ) and stored at RT.  
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Immunohistochemical testing in swine nodose ganglia  
 The nodose ganglion tissue was unable to be perfused due to the requirements of the primary 
research project, and thus, was lower quality than would be acceptable for a full investigation using this 
tissue. The following antibodies were tested in the tissue, with all antibody tests including sets with and 
without antigen retrieval: 1.) Anti-furin monoclonal antibody, ab1831495, Abcam, San Francisco, CA 2.) 
Anti-furin polyclonal antibody, ab28547, Abcam, San Francisco, CA 3.) Anti-furin polyclonal antibody, 
ab3467, Abcam, San Francisco and 4.) Anti-SirT1 polyclonal antibody, 13161-AP; ProteinTech, 
Rosemont, IL. The results of this antibody testing showed that only the ab28547 monoclonal antibody 
with antigen retrieval was suitable for ROI investigation, and thus this antibody and procedure was used 
for the above experiments. These findings may suggest that monoclonal antibodies with antigen retrieval 
are preferable for immunohistochemical procedures in swine nodose ganglion tissue.  
Quantification  
 Intestinal tissue sections were visualized using a NanoZoomer Digital Pathology System 
(Hamamatsu, Hamamatsu City, Japan) using a 40x objective and NDP Scan software. Quantification was 
performed by visual inspection of the images on a desktop computer using NDP View 2 software by one 
individual that was blinded to the treatments. Neuron number and glial cell number per mm2 were 
determined in slides that underwent a Nissl stain. Relative optical density was determined in slides that 
underwent immunohistochemical staining with an anti-furin primary antibody by using the measure 
function in ImageJ.  
Statistical analysis 
 All variables were analyzed using Number Crunching Statistical Software (NCSS LLC, 
Kaysville, UT). Results were expressed as Mean ± SEM (n = 2-3). Measures of differences between lean 
and obese groups in neuron density, glial cell density, or furin ROI were performed for each ganglion (left 
or right) using Student’s t tests. Assumptions of normality, homogeneity of variance, and independence 
were met. Differences between groups were considered statistically significant if p < 0.05. 
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3.3 Results 
Effect of obesity on neuron density in the nodose ganglion 
 Obesity increased neuron density in the left nodose ganglion compared with lean animals (Fig. 
5A). However, there was no effect of obesity on neuron density in the right nodose ganglion (Fig. 5B).  
Effect of obesity on glial cell density in the nodose ganglion 
 There was no effect of obesity on glia cell density in the left (Fig. 6A) or right (Fig. 6B) nodose 
ganglion.  
Effect of obesity on furin protein relative optical density in the nodose ganglion 
 There was no effect of obesity on furin protein relative optical density (ROI) in the left (Fig. 7A) 
or right (Fig. 7B) nodose ganglion.  
3.4 Conclusions  
	 These findings suggest that obesity increases neuron number in the left nodose ganglion. This 
increase in neuron number may be a result of neural proliferation. Neural proliferation in the adult nodose 
ganglion has been demonstrated after injury (Gallaher, Ryu, Larios, Sprunger, & Czaja, 2011), and our 
findings may add obesity as the second phenomenon capable of inducing this effect. Interestingly, the 
effect was seen in the left nodose ganglion, but not the right. As the left nodose ganglion innervates a 
disproportionately high level of the GI tract compared with the right nodose ganglion (Berthoud, 
Patterson, Neumann, & Neuhuber, 1997; Wang & Powley, 2000), the lateralization of this effect may be 
linked to greater amounts of GI sensory stimuli sent to the left nodose ganglion.  Despite these interesting 
results, further experiments must be pursued to increase power and confirm findings from this pilot 
experiment.  
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3.5 Figures and captions 
Figure 5 
 
Figure 5. Effect of obesity on neuron density in the nodose ganglion.  Obesity increases neuron density 
in increased in the left nodose ganglion (A), but there is no effect of obesity on neuron density in the right 
nodose ganglion (B). Representative image of Nissl stained tissue used to quantify neuron and glial cell 
density (C), scale bar, 100 µm.   
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Figure 6 
 
Figure 6. Effect of obesity on glial cell density in the nodose ganglion. There is no effect of obesity on 
glial cell density in the left (A) or right (B) nodose ganglion.  
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Figure 7 
 
Figure 7. Effect of obesity on furin relative optical intensity in the nodose ganglion.  There is no 
effect of obesity on furin relative optical density (ROI) in the left (A) or right (B) nodose ganglion. 
Representative image of tissue with furin immunohistochemistry used to quantify furin ROI (C), scale 
bar, 100 µm.   
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CHAPTER 4: EVIDENCE FOR A DIRECT EFFECT OF THE AUTONOMIC NERVOUS 
SYSTEM ON INTESTINAL EPITHELIAL STEM CELL PROLIFERATION 
 
(Published in Physiological Reports; Citation: Davis EA, Zhou W & Dailey MJ (2018). Evidence for a 
direct effect of the autonomic nervous system on intestinal epithelial stem cell proliferation. Physiol Rep 
6, e13745.) 
 
4.1 Abstract 
The sympathetic (SNS) and parasympathetic (PNS) branches of the autonomic nervous system 
have been implicated in the modulation of the renewal of many tissues, including the intestinal 
epithelium. However, it is not known whether these mechanisms are direct, requiring an interaction 
between autonomic neurotransmitters and receptors on proliferating epithelial cells. To evaluate the 
existence of a molecular framework for a direct effect of the SNS or PNS on intestinal epithelial renewal, 
we measured gene expression for the main autonomic neurotransmitter receptors in this tissue. We 
separately evaluated intestinal epithelial regions comprised of the stem, progenitor, and mature cells, 
which allowed us to investigate the distinct contributions of each cell population to this proposed 
autonomic effect. Notably, we found that the stem cells expressed the receptors for the SNS-associated 
alpha2A adrenoreceptor and the PNS-associated muscarinic acetylcholine receptors (M1 and M3). In a 
separate experiment, we found that the application of norepinephrine or acetylcholine decreases the 
expression of cyclin D1, a gene necessary for cell cycle progression, in intestinal epithelial organoids 
compared with controls (p < 0.05). Together, these results provide evidence of a direct mechanism for the 
autonomic nervous system influence on intestinal epithelial stem cell proliferation.  
4.2 Introduction 
The intestinal epithelium is critical for nutrient absorption, hormone release, and immune barrier 
function. In order to maintain proper tissue function, intestinal epithelial cells undergo rapid turnover, a 
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process that is driven by proliferating intestinal epithelial stem cells in the crypt (Barker et al., 2007). The 
stem cells divide to produce transit amplifying (TA) progenitor cells, which proliferate and differentiate 
as they migrate up the crypt. Once they reach the base of the villus, these cells are fully differentiated, and 
will serve their mature functions until eventually undergoing apoptosis at the villus tip (Fig. 8). Both 
branches of the autonomic nervous system (ANS) have been implicated in the control of this turnover 
process, as denervation (surgical or chemical) of either sympathetic (SNS) or parasympathetic (PNS) 
nerves to the intestine alters intestinal epithelial cell proliferation (Tutton & Helme, 1974; Musso et al., 
1975a; Tsibulevskii & Orlova, 1976; Lachat & Goncalves, 1978; Kennedy et al., 1983; Callaghan, 1991). 
However, it is not known if these changes occur via direct or indirect mechanisms. Previous studies may 
have detected indirect effects on proliferation due to post denervation-induced changes in food intake, 
inflammation, or other factors that can alter intestinal epithelial cell proliferation (Dailey, 2014; Slater et 
al., 2017). In contrast, a direct effect could potentially be driven by autonomic neurotransmitters binding 
to receptors localized on proliferating cells of the intestinal epithelium. SNS and PNS neurotransmitter 
receptors are expressed by cells of the intestinal epithelium (Valet et al., 1993; Greig & Cowles, 2017b) 
and mediate various epithelial functions (e.g., fluid transport and hormone release) (Greenwood et al., 
1987; Rocca & Brubaker, 1999), but whether the stem cells or TA cells express these receptors and 
mediate changes in the cell cycle has not been investigated. Because a direct effect of the SNS and PNS 
has been shown to alter the regeneration of other tissues [e.g., liver (Cruise et al., 1985; Oben et al., 
2003a)], we postulate that the SNS and PNS could modulate intestinal epithelial regeneration through 
direct control of the cell cycle downstream of neurotransmitter receptors.  
To determine if the main neurotransmitters for the SNS and PNS, norepinephrine (NE) and 
acetylcholine (ACh), can mediate a direct action on the proliferating cells of the intestinal epithelium, we 
evaluated gene expression for the alpha2A adrenoreceptor (Adra2a) and the muscarinic acetylcholine 
receptors M1-M5 (Chrm1-5, also known as cholinergic receptor muscarinic 1-5), which were selected due 
to previous studies localizing them within the intestine and implicating them in control of proliferation 
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(Valet et al., 1993; Schaak et al., 2000; Greig & Cowles, 2017b). We analyzed the expression of these 
receptors in the two major regions of the intestinal epithelium, the crypts (where the proliferating cells 
reside) and the villi (where the mature cells reside) in mice. Then, we further analyzed whether crypt cell 
receptor expression occurred in the stem cells or the other non-stem crypt cells (the vast majority of 
which are the TA cells). In addition, to investigate the presence of the molecular framework for the 
autonomic nervous system to influence intestinal epithelial turnover, we also investigated whether NE or 
ACh could induce changes in the cell cycle. We used intestinal epithelial organoids grown in vitro to 
measure the response of NE or ACh on the expression of cyclin D1 (Ccnd1), which is critical for the 
progression of the cell cycle from G1 to the S phase and remains at high levels until the end of mitosis. 
Both alpha2A adrenoreceptor and muscarinic acetylcholine receptor signaling have been linked to 
changes in cyclin D1 in other tissues, resulting in changes in the cell cycle and/or proliferation 
(Arredondo et al., 2003; Karkoulias & Flordellis, 2007; Braga et al., 2013; Peng et al., 2013). Thus, these 
experiments begin to describe the molecular components and physiology through which a direct ANS 
control of stem cell proliferation and tissue regeneration may occur.  
4.3 Materials and methods 
Ethical Approval 
All procedures were approved by the Institutional Animal Care and Use Committee at the 
University of Illinois at Urbana-Champaign, which operates under the Association for Assessment and 
Accreditation of Laboratory Animal Care International guidelines.  
 Animals  
Adult male Lgr5-GFP (B6.129P2-Lgr5tm1(cre/ERT2)Cle/J; n = 3 for receptor expression 
experiment) and wild type (C57BL/6J; n = 3 for the receptor expression experiment and n = 3 for the 
proliferation-related gene expression experiment) mice were used (Jackson Laboratory, Bar Harbor, ME). 
These transgenic animals were selected for their global and constitutive expression of a green fluorescent 
protein tag on the intestinal epithelial stem cell marker Lgr5 (Barker et al., 2007). An n = 3 mice per 
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group was chosen based on previously published data investigating mRNA expression differences 
between IESCs and other crypt cells (Mustata et al., 2011; Akcora et al., 2013; Tsai et al., 2014; Kechele 
et al., 2017; Zhou et al., 2018). Animals were single housed in shoebox cages and maintained with ad 
libitum access to tap water and laboratory chow (Teklad 22/5, Envigo, Madison, WI) on a 12:12 
light:dark cycle (lights on 0700) in a climate-controlled room (temperature = 21±2°C and humidity = 
50±10%).  
Isolation of small intestinal crypts and villi 
Small intestinal crypts were isolated as previously described (Sato & Clevers, 2013; Zhou et al., 
2018). Briefly, the animals were anesthetized under 3% isoflurane at 1.5L/min in an anesthesia induction 
chamber and then decapitated. The entire small intestine was harvested, opened longitudinally and 
washed with cold 1x PBS to remove luminal contents. The villi were scraped off with a coverslip. Villi 
from the wild type mice (biological replicates, n = 3) were collected into a falcon tube, and centrifuged at 
300 g at 4°C for 5 min. The supernatant was removed and the pellet containing the villus cells was 
immediately stored at -80°C to await processing. The remaining intestinal tissue was cut into 2-4 mm 
pieces with scissors and washed 5-10 times with cold 1x PBS until the supernatant was almost clear. 
Tissue fragments were incubated with 2 mM EDTA (Fisher Scientific, Pittsburgh, PA) and gently rocked 
at 4°C for 30 min. After removal of EDTA, tissue fragments were washed with 1x PBS 3 times. The 
supernatant was then collected and passed through a 70-um cell strainer (Corning, Corning, NY) and 
centrifuged at 300 g at 4°C for 5 min. The cell pellet was resuspended with basal culture medium 
[Advanced DMEM/F-12 Medium (Gibco, Grand Island, NY) containing 2 mM GlutaMax (Gibco, Grand 
Island, NY), 10 mM HEPES (Gibco, Grand Island, NY) and 100 U/mL Penicillin-Streptomycin (Gibco, 
Grand Island, NY)] and centrifuged at 300 g 4°C for 5 min. The supernatant was removed. The isolated 
crypts from the wild type mice (biological replicates, n = 3) were immediately stored at -80°C to await 
processing. The isolated crypts from the Lgr5-GFP mice (biological replicates, n = 3) were used for 
intestinal epithelial stem cell isolation (see Isolation of IESCs). Both sets of samples were then processed 
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to evaluate gene expression (see Quantitative real time polymerase chain reaction). Isolated crypts from 
the second set of wild type mice were grown into organoids (see Organoid growth).  
Isolation of IESCs 
Isolated crypts from Lgr5-GFP mice were resuspended with single cell dissociation medium 
[basal culture medium containing 1x N2 (Gibco, Grand Island, NY), 1x B27 (Gibco, Grand Island, NY) 
and 10 uM Y-27632 (Sigma-Aldrich, St. Louis, MO)] at 37 °C for 40 min. During incubation, the cell 
suspension was resuspended every 10 min. Dissociated cells were passed through a 40-um cell strainer 
(pluriSelect, Leipzig, Germany), followed by a 20-um cell strainer (pluriSelect, Leipzig, Germany) and 
centrifuged at 300 g at 4 °C for 5 min. Single, live IESCs were sorted as GFPhigh (stem cells) or GFPlow 
(other crypt cells) by fluorescence-activated cell sorting (FACS) with a BD FACS ARIA II sorter into 
single cell dissociation medium as previously defined cell populations (Sato & Clevers, 2013). Dead cells 
were excluded from the FACS with the viability dye propidium iodide (Invitrogen, Carlsbad, CA). Sorted 
cells were centrifuged at 300 g 4°C for 5 min, supernatants were removed, and the pellet was immediately 
stored at -80°C to await processing for qPCR (see Quantitative real-time polymerase chain reaction).  
Organoid growth  
After the final centrifugation in the crypt isolation process, the supernatant was removed and 
crypts were re-suspended in Matrigel (Corning Inc., Corning, NY) and plated in triplicate (three technical 
replicates (i.e., wells) per treatment from each biological replicate) onto a pre-warmed 24-well plate. 
Matrigel-crypt mix was applied to the center of each well and then allowed to solidify for 10 minutes in a 
37°C incubator. Once the Matrigel solidified, 500 µL of IntestiCult Organoid Growth Medium (StemCell 
Technologies, Cambridge, MA) was added per well. Media were changed after 4 days of growth. After 5 
days of growth, organoids received one of 3 treatments: 1 µM norepinephrine (A0937, Sigma Aldrich, St. 
Louis, MO), 1 µM acetylcholine (A2261, Sigma Aldrich, St. Louis, MO), or a vehicle control. The 
physiological neurotransmitters of the ANS were used instead of pharmacological agents targeting 
specific autonomic neurotransmitter receptors in order to most closely mimic the in vivo physiology of 
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this system. Doses were chosen based on other studies demonstrating NE- or ACh-induced proliferation 
in other cell types in vitro (Cruise et al., 1985; Oben et al., 2003a; Oben et al., 2003b; Liu et al., 2014b; 
Liu et al., 2017). 24 hours after treatment administration, Matrigel was dissolved using 1 mL QIAzol 
(QIAGEN; Germantown, MD), the cells vortexed, and stored at -80°C to await processing (see 
Quantitative real-time polymerase chain reaction).  
Quantitative real-time polymerase chain reaction (qPCR)  
Total RNA was extracted from samples using RNeasy Plus Universal Mini Kit (Qiagen, Hilden, 
Germany). RNA was reverse transcribed to cDNA using QuantiTect Reverse Transcription Kit (Qiagen, 
Hilden, Germany). qPCR was performed with TaqMan Universal PCR Master Mix (Applied Biosystems, 
Foster City, CA) and TaqMan probes (Applied Biosystems, Foster City, CA) using Applied Biosystems 
QuantStudioTM 7 Flex Real-Time PCR System. Negative reverse-transcribed samples were generated and 
all reactions were carried out in triplicate. Technical triplicates were generated from each biological 
sample in the autonomic neurotransmitter gene expression experiment, and from each cell culture well in 
the experiment using organoids. The following TaqMan probes were used: Adra2a: Mm00845383_s1, 
Chrm1: Mm00432509_s1, Chrm2: Mm01701855_s1, Chrm3: Mm00446300_s1, Chrm4: 
Mm00432514_s1, Chrm5: Mm01701883_s1, Ccnd1: Mm00432359_m1, Gapdh: Mm99999915_g1. To 
determine relative expression values, the 2-ΔΔCt method was used, where triplicate Ct values for each 
sample were averaged and subtracted from those derived from GAPDH. 
Confirmation of compliance  
The investigators understand the ethical principles under which Experimental Physiology 
operates. This work complies with the animal ethics checklist outlined in ‘Principles and Standards for 
Reporting Animal Experiments in Experimental Physiology.  
Data analysis  
All variables were analyzed using Number Crunching Statistical Software (NCSS LLC, 
Kaysville, UT). Data were expressed as fold change compared to control, and are expressed as mean fold 
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change ± SD. Two-tailed independent two-sample student’s t-tests were used to determine differences 
between: 1) Adra2a expression in villi versus crypts, 2) Chrm1 expression in villi versus crypts, 3) Chrm3 
expression in villi versus crypts, 4) Chrm4 expression in villi versus crypts, 5) Adra2a expression in stem 
cells versus other crypt cells, 6) Chrm1 expression in stem cells versus other crypt cells 7) Chrm3 
expression in stem cells versus other crypt cells, 8) Ccnd1 expression between NE treatment and control, 
and 9) Ccnd1 expression between ACh treatment and control. Assumptions of normality, homogeneity of 
variance, and independence were met. No inclusion or exclusion criteria were applied to the datasets. 
Differences were considered to be statistically significant at p < 0.05.  
4.4 Results 
Autonomic neurotransmitter receptor expression in the intestinal epithelial crypts and villi 
We found that the crypts expressed Adra2a (122.3-fold ± 45.8), Chrm1 (26.4-fold ± 0.8), Chrm3 
(17.2-fold ± 8.4), and Chrm4 (2.4-fold ± 0.7), but there was no detectable expression of Chrm2 nor 
Chrm5 (Fig. 9). We found that the villi expressed Adra2a (2.4-fold ± 0.7), Chrm1 (6.2-fold ± 0.2), 
Chrm2 (1.0-fold ± 0.7), Chrm3 (5.1-fold ± 0.4), and Chrm4 (3.6-fold ± 0.7), but there was no detectable 
expression of Chrm5 (Fig. 9). Adra2a was expressed at higher levels in the crypt compared with the villi 
(p = 0.015; crypt: 122.3-fold ± 45.8 versus villi: 2.4-fold ± 0.7, estimated difference: 119.9-fold, 95% 
confidence limits of difference: 78.4 ≤ 𝑑 ≤ 161.5; Fig. 9). Similarly, Chrm1 was also expressed at higher 
levels in the crypt compared with the villi (p = 2.0x10-6; crypt: 26.4-fold ± 0.8-fold versus villi: 6.2-
fold ± 0.2 estimated difference: 20.2-fold, 95% confidence limits of the difference: 18.9 ≤ 𝑑 ≤ 21.6, Fig. 
9).  
Autonomic neurotransmitter receptor expression in intestinal epithelial stem cells and other crypt cells 
We found that the stem cells expressed Adra2a (13.5-fold ± 2.8), Chrm1 (5.9-fold ± 0.9), and 
Chrm3 (3.0-fold ± 2.0) (Fig. 10). We found that the other crypt cells also expressed Adra2a (6.4-
fold ± 2.0), Chrm1 (4.9-fold ± 0.6), and Chrm3 (1.0-fold ± 0.03) (Fig. 10). Adra2a was expressed in the 
stem cells to a higher level than the other crypt cells (p = 0.022; stem cells: 13.5-fold ± 2.8 versus other 
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crypt cells: 6.4-fold ± 2.0, estimated difference: 7.1-fold, 95 % confidence limits of the difference: 1.6 ≤ 𝑑 ≤12.5, Fig. 10).  
Effect of autonomic neurotransmitters on expression of a proliferation-related gene in intestinal epithelial 
organoids 
NE decreased relative mRNA expression of Ccnd1 in intestinal epithelial organoids compared 
with control (p = 0.037; NE: 0.78-fold ± 0.06 versus control: 1.0-fold ± 0.10, estimated difference: 0.21-
fold, 95% confidence limits of the difference: 0.02 ≤ 𝑑 ≤0.41, Fig. 11A). ACh decreased expression of 
Ccnd1 intestinal epithelial organoids compared with control (p = 0.047; ACh: 0.77-fold ± 0.10 versus 
control: 1.0-fold ± 0.10, estimated difference: 0.23-fold, 95% confidence limits of the difference: 0.003 ≤ 𝑑 ≤ 0.36, Fig. 11B).  
4.5 Discussion 
The present study determined that the SNS and PNS autonomic neurotransmitter receptors are 
expressed in the villus, crypt and stem cells of the intestinal epithelium. Notably, Adra2a, Chrm1, and 
Chrm3 were expressed in both populations of proliferating cells, the stem cells and the TA cells. In 
addition, we found that application of NE or ACh decreased the expression of cyclin D1 in intestinal 
epithelial organoids. Together, these findings suggest that both the SNS and PNS may be capable of 
directly influencing intestinal epithelial cell proliferation by a direct modulation of the stem cells.  
 SNS and PNS nerves come in close contact with the intestinal epithelium, which supports the idea 
of a direct autonomic effect on intestinal epithelial cell proliferation and tissue renewal (Gabella & Costa, 
1968; Bohorquez et al., 2015). NE and ACh released from these terminals may bind to receptors on the 
stem cells and/or the TA cells to affect proliferation. Both NE and ACh have been shown to directly alter 
proliferation in other cell types, mediated through a variety of adrenoreceptor and muscarinic receptor 
subtypes (Cruise et al., 1985; Geloen et al., 1988; Bronnikov et al., 1992; Oben et al., 2003a; Oben et al., 
2003b; Liu et al., 2014b; Sloniecka et al., 2015; Morgan et al., 2016; Liu et al., 2017). However, in 
contrast to other organ systems, the gastrointestinal (GI) tract is innervated by the enteric nervous system 
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(ENS). The ENS makes synaptic contacts with both the SNS and PNS, but also provides intrinsic neural 
control of gastrointestinal functions independent of extrinsic innervation. Due to input from multiple 
neural systems, the source of neurotransmitters effecting changes in intestinal epithelial cells must be 
considered. All noradrenergic innervation of the GI tract is sympathetic, as the ENS does not utilize NE 
as a neurotransmitter (McConalogue & Furness, 1994). Thus, our results demonstrating that NE alters 
expression of cyclin D1 can be attributed exclusively to the SNS, without participation of enteric 
neurotransmission. In contrast, since ACh is both a PNS and ENS neurotransmitter, it is not possible to 
elucidate the effect of PNS versus ENS sources of ACh in the present experiment alone. However, 
considering PNS denervation alters intestinal epithelial cell proliferation despite enteric circuitry 
remaining intact (Musso et al., 1975a; Tsibulevskii & Orlova, 1976; Lachat & Goncalves, 1978; 
Callaghan, 1991), it is plausible that the PNS participates in mediating intestinal epithelial cell 
proliferation via ACh signaling. Thus, our results support the narrative that the intestinal epithelium is 
among the tissues in which regeneration is under direct SNS and PNS control.  
 We found that both NE and ACh both decrease expression of cyclin D1 in intestinal epithelial 
cells in vitro. As the effects of the SNS and PNS are usually thought of as antagonistic, opposing effects 
of NE and ACh on cyclin D1 might be expected. However, a more nuanced description of the ANS 
includes cooperative function of the SNS and PNS on certain organs (e.g., sexual organs (Wehrwein et 
al., 2016)). This SNS and PNS cooperation is also seen in regard to control of cell proliferation, as NE 
and ACh both increase proliferation of hepatic myofibroblastic stellate cells, reflecting the dual 
participation of the SNS and PNS in liver regeneration after injury (Oben et al., 2003a; Oben et al., 
2003b). Similarly, the SNS and PNS may differentially coordinate suppression of intestinal epithelial cell 
proliferation in vivo. This may be a strategy for the ANS to inhibit proliferation during specific body 
states. When sympathetic tone is high, the SNS coordinates an overall decrease in energy and resources to 
the intestine (Browning & Travagli, 2014; Wehrwein et al., 2016), which may subsequently limit the 
energy available for cell proliferation. In contrast, PNS tone is increased during digestion, which is 
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accompanied by increased cellular metabolism and subsequent reactive oxygen species (ROS) byproducts 
(Granger et al., 2015). Because ROS induces DNA damage that can cause DNA synthesis errors, this may 
not be an ideal environment for cell proliferation (Oberreuther-Moschner et al., 2005; Cadet & Wagner, 
2013). Thus, by decreasing cyclin D1 expression under conditions of exceptionally high SNS or PNS 
tone, the ANS may be restricting progression of the cell cycle during physiological states that are 
unfavorable for proliferation. The present study also revealed which autonomic neurotransmitter receptors 
are expressed in proliferating cell populations of the intestinal epithelium, thus identifying candidates for 
mediation of this proposed direct effect of the ANS on proliferation. Previous research has shown that the 
disruption of these receptors can modulate proliferation. Intestinal epithelial cell proliferation is increased 
in transgenic mice with global knockouts of M1 (Chrm1) or M3 (Chrm3) compared with wild type 
controls (Greig & Cowles, 2017b). In addition, proliferation is altered in a CaCo2 cell line model of 
intestinal epithelial cells transfected to express the alpha2A adrenoreceptor (Adra2a) (Schaak et al., 
2000). The alpha2A adrenoreceptor receptor is traditionally thought of as a presynaptic receptor that 
modulates neurotransmission (Docherty, 1998). However, alpha2A adrenoreceptor localization on 
intestinal epithelial cells is, by definition, post-synaptic. Thus, these cells are poised to alter target cell 
function, as is seen with localization of alpha2A adrenoreceptor on pancreatic beta cells, which function 
to decrease insulin release (Fagerholm et al., 2004; Rosengren et al., 2010). Therefore, under homeostatic 
conditions, it is likely that the specific receptors we have identified on the stem cells and the TA cells are 
directly modulating proliferation via autonomic neurotransmitter signaling.  
We can now use the results from this study as a framework to definitively demonstrate which 
specific proliferating cell subpopulation is driving these changes in proliferation-related events: the stem 
cells, the TA cells, or a combination of both cell types. Stem cell isolation techniques used in this paper 
can be further employed to answer these research questions, which will add to the understanding of the 
interactions between somatic stem cells and the autonomic nervous system. In addition, we can also 
reveal the exact intracellular signaling mechanisms that are causing changes in cyclin D1 downstream of 
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the autonomic neurotransmitter receptors. Our current results provide a foundation for in-depth 
exploration of neural control of stem cells in the intestinal epithelium, and can be expanded to investigate 
stem cells from other tissues throughout the body. Further research on this topic is necessary to elucidate 
the mechanistic details and physiological function of this phenomenon.  
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4.6 Figures and captions 
Figure 8 
 
Figure 8. Intestinal epithelial morphology. Stem cells (black) reside at the base of the crypt. Other crypt 
cells (white) are primarily comprised of transit amplifying (TA) progenitor cells. The stem cells and TA 
cells proliferate to produce mature intestinal epithelial cells (gray), which reside in the villus and serve the 
major functions of the intestinal epithelium. 
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Figure 9  
 
Figure 9. Expression of autonomic neurotransmitter receptor genes in villus and crypt cells. Relative 
mRNA expression of Adra2a, Chrm1, Chrm2, Chrm3, Chrm4, and Chrm5 in the intestinal epithelial villi 
and crypts (n = 3, * p < 0.05).  
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Figure 10  
 
Figure 10. Expression of autonomic neurotransmitter receptor genes in stem cells and other crypt 
cells. Relative mRNA expression of Adra2a, Chrm1, and Chrm3 in the intestinal epithelial stem cells and 
other crypt cells (n = 3, * p < 0.05).  
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Figure 11     
 
Figure 11. Effect of autonomic neurotransmitters on expression of a proliferation-related gene in 
intestinal epithelial organoids. (A) Effect of NE on relative Ccnd1 mRNA expression in intestinal 
epithelial organoids compared with control (n = 3; * p < 0.05). (B) Effect of ACh on relative Ccnd1 
mRNA expression in intestinal epithelial organoids compared with control (n = 3; * p < 0.05). 
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CHAPTER 5: EFFECT OF NOREPINEPHRINE ON INTESTINAL EPITHELIAL STEM CELL 
PROLIFERATION 
 
PART I: Alpha2A adrenoreceptor influence on intestinal epithelial stem cell proliferation 
PART II: Effect of norepinephrine on intestinal epithelial crypt cell proliferation  
 
Chapter Introduction 
 The development of intestinal epithelial organoids has allowed primary cell culture of intestinal 
epithelial cells for the first time (Sato & Clevers, 2013). These organoids include all of the cell types of 
the intestinal epithelium found in vivo, including stem cells, progenitor cells, and mature cell types (e.g., 
enterocytes, enteroendocrine cells, goblet cells, paneth cells) (Sato & Clevers, 2013). Organoids are also 
able to recapitulate the crypt-villus morphology found in vivo when culturing using a 3-dimensional (3-D) 
matrix, which provides a scaffolding for this morphology to develop (Sato & Clevers, 2013). Despite 
being an innovative and physiologically relevant model, the use of organoids presents several issues when 
measuring proliferation compared with traditional cell culture methods. Below, we provide a description 
of each of these limitations and how they interfere with the most common methods to measure 
proliferation in vitro. We also describe the strategies we used to minimize variability in the subsequently 
presented experiments (Part I and Part II), which aimed to accurately measure the effect of norepinephrine 
on intestinal epithelial organoid proliferation.  
  A persistent problem with measuring proliferation in organoids is the inability to control for 
starting cell number between wells and rate of proliferation of these cells. To generate organoids in vitro, 
intestinal epithelial crypts are harvested, and these crypts remain in their aggregate cell clusters when 
plated. Although equal crypt numbers are plated in each well, these crypts vary in cell number and 
therefore it is impossible to control for equal cell number per well at the start of the experiment. This is in 
contrast to traditional cell culture protocols that use dissociated single cells, which can be plated using an 
accurate and equal number of cells per well. It is possible to isolate and plate equal numbers of stem cells, 
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which can ameliorate the cell number issue that is a limitation to working with crypts. However, after 
plating, both crypts and stem cells continually proliferate and grow into organoids, but these cells do not 
proliferate at equal rates. This also contributes to variability in experiments using organoids. Overall, 
these sources of variability may reduce the ability to detect differences in proliferation between 
experimental groups when performing experiments using organoids. 
 The 3-D matrix that is required to grow organoids can also interfere with proliferation 
measurements. These 3-D matrices mimic basement membranes in order to provide an extracellular 
matrix for the organoids to adhere to and use it as a scaffold to grow (Kleinman & Martin, 2005). As 
these matrices are biologics that contain proteins, they will produce background staining with the use of 
antibody-based methods of measuring proliferation. In addition, these proteins will cause the matrix to 
autofluoresce when using methods with fluorophores. Subsequently, unwanted staining may interfere 
with accurate quantification of cell proliferation in 3-D matrices. In addition, methods for measuring 
proliferation that require imaging of these 3-D matrix structures must rely on confocal microscopy to 
image the entire x, y and z-planes (Blackmore et al., 2017). This adds an additional burden of time and 
specialized equipment in comparison to imaging of traditional 2-D cell cultures. Furthermore, due to the 
expansion and growth of these organoids in all directions within a 3-D space, it is impossible to track the 
growth of the same organoids over time. To address the issues surrounding quantification of proliferation 
of cells embedded in matrices, matrix dissociation and cell recovery is possible. However, this protocol 
requires time to release the organoids from the matrix (Nozaki et al., 2016), and then requires the use of 
harsh dissociation buffers to dissociate the cells that may cause cell death (Miyoshi & Stappenbeck, 
2013). Given this variety of limitations, it is clear that 3-D matrices require special consideration when 
selecting methods to measure proliferation.  
 There are a variety of methods to measure proliferation in vitro, with both direct and indirect 
methods available. Direct measurements of proliferation require the quantification of proliferative events 
in a cell population. A common method is the use of thymidine analogs, such as 5-bromo-2´-deoxyuridine 
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(BrdU) or 5-ethynyl-2´-deoxyuridine (EdU). These molecules replace thymidine nucleotides in DNA 
during synthesis. Following integration of the thymidine analog, the cells are labeled using antibody-
based immunocytochemistry for BrdU, or click chemistry that affixes a fluorescent tag to EdU. Through 
this process, all cells that have undergone proliferation since the addition of the thymidine analog are 
identified and can be subsequently quantified (Cavanagh et al., 2011). Other direct methods include 
antibody-based immunocytochemical labeling of proliferation markers, such as the protein Ki67 (Brown 
& Gatter, 1990). In context of the issues regarding measurement of proliferation in organoids described 
above, all of these direct methods would require either 1) time consuming 3-D confocal imaging and 
counting while navigating undesired background staining/autofluorescence from the matrix, or 2) matrix 
dissociation and subsequent evaluation with a live/dead assay followed by cell counting by flow 
cytometry or a coulter counter. For these reasons, indirect measures of proliferation are generally 
preferable when using organoids.  
 Metabolic proliferation assays are a popular method indirect measure of proliferation. These 
assays use tetrazolium salts, including MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-Diphenyltetrazolium 
Bromide), WST-1 (water soluble tetrazolium salt), or XTT (2,3-Bis-(2-Methoxy-4-Nitro-5-Sulfophenyl)-
2H-Tetrazolium-5-Carboxanilide). These assays measure markers of cell metabolism as an indirect 
indicator of proliferation. The reagents produce a dye that directly correlates to the number of 
metabolically active cells in the culture, which can then be measured as an indirect measure of 
proliferation using a plate reader (Präbst et al., 2017). Metabolic proliferation assays offer advantages 
when it comes to their use with 3-D matrices, as there is no need to image the cultures nor dissociate the 
cells. However, there is evidence that there are discrepancies between metabolic activity and cell 
proliferation (Maghni et al., 1999; Quent et al., 2010), which ultimately makes metabolic assays an 
unreliable choice for measuring proliferation.  
 Another indirect option for measuring proliferation is the use of a DNA-binding fluorescent dye. 
The amount of dye bound to DNA directly correlates to the total cell number, and therefore the dye 
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content in the sample can be measured by a plate reader to quantify total cell number as an indirect 
measure of proliferation (Jones et al., 2001). This method is advantageous due to the ability to quantify 
proliferation in a high-throughput manner without imaging or dissociating the cells for further analysis. 
However, the autofluorescence of the matrigel when measuring DNA content with a fluorescent dye can 
artificially increase the measurement of total cell number. As in all of the proliferation techniques, the 
inability to control for initial cell number when using organoids adds to variability to the results of this 
assay. Despite these limitations, the DNA-binding fluorescent dye is the most suitable option for 
determining proliferation in organoids.  
 To determine the effect of norepinephrine on intestinal epithelial cell proliferation, we conducted 
two experiments using the CyQUANT proliferation assay, which uses a DNA-binding fluorescent dye to 
indirectly measure proliferation as described above (Jones et al., 2001). These experiments are outlined in 
Chapter 5a and 5b. In both of the experiments, we controlled for the autofluorescence of the matrigel by 
plating a subset of matrigel blanks without any cells in them and then subtracting the average blank value 
from all of the experimental values. Furthermore, we reported our results in fold changes to standardize 
the variability within groups due to the inability to control for initial cell numbers. For the experiment in 
Chapter 5a, we used n = 3 mice to determine the effect of norepinephrine on organoid proliferation. Due 
to the high variability in the raw data of this experiment, we repeated a similar experiment in Chapter 5b 
and employed several techniques to reduce variability. In this second experiment, we doubled our animal 
numbers to n = 6, used crypts instead of organoids in order to reduce the variability in cell number that 
may result during growth of isolated crypts into organoids, and eliminated the contribution of dead cells 
to the total DNA content measurement by using a background suppression agent. We found different 
results in these two experiments, which we believe demonstrates the inaccuracy of measuring 
proliferation in intestinal epithelial organoids. Due to these discrepancies, we cannot make confident 
interpretations of these datasets at this time. We conclude that it is important to critically evaluate 
methods for measuring proliferation in organoids, as it is an often overlooked technical issue that can alter 
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results and interpretations of scientific research. Future technical advancements in this field will hopefully 
allow accurate data collection on proliferation from not only intestinal epithelial organoids, but organoids 
derived from all tissues.  
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PART I: ALPHA2A ADRENORECEPTOR INFLUENCE ON INTESTINAL EPITHELIAL STEM 
CELL PROLIFERATION  
 
5.1 Abstract 
 The intestinal epithelium is critical for nutrient absorption, immune function, and hormone 
release. The mature cell types that are responsible for these functions are produced by crypt base 
columnar (CBC) stem cells located within the intestinal crypts. These stem cells constitutively divide to 
produce complete turnover of the entire intestinal epithelial layer every few days. The division of the 
CBC stem cells can be influenced by a variety of factors, including nutrient availability. There is research 
that suggests the sympathetic nervous system can contribute to changes in stem cell proliferation. 
However, it is not known whether this effect is direct via the CBC stem cells, or instead through an 
indirect mechanism. Thus, we tested whether CBC stem cells express alpha2A adrenoreceptors (α2A-
ARs), a receptor subtype utilized by norepinephrine (NE; the primary neurotransmitter of the SNS) and 
whether NE induces proliferation of intestinal epithelial organoids in vitro. Results showed that α2A-ARs 
mRNA is expressed in CBC stem cells and that there is a trend towards higher expression of α2A-AR 
mRNA in CBC stem cells compared with other cells of the crypt. We also found a significant decrease in 
proliferation after application of NE to organoids in vitro (p<.05). These data support a role for the SNS 
in regulation of CBC stem cells proliferation, which may influence intestinal epithelial size and function 
as a whole.  
5.2 Introduction 
 The intestinal epithelium is a single layer of cells that form the inner lining of the small intestine. 
The mature cells of the intestinal epithelium absorb nutrients (enterocytes), secrete hormones 
(enteroendocrine cells), and secrete mucus to create an immune barrier (goblet cells) (Schaak et al., 
2000). To replace these mature cells as they die off, crypt base columnar (CBC) intestinal epithelial stem 
cells located in the base of the crypt divide constitutively to produce daughter cells of each cell type. The 
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newly produced daughter cells, which are progenitor cells that are referred to as transit amplifying (TA) 
cells, differentiate and continue to divide as they migrate up the crypt. As these cells reach maturity, they 
move into the villi. When the cells reach the apex of the villus, they undergo apoptosis and are sloughed 
off into the lumen of the intestine. Via this process, complete turnover of the entire intestinal epithelial 
layer occurs every three to five days (van der Flier & Clevers, 2009). Consequently, proper CBC stem cell 
proliferation is critical to maintain the morphology and function of the entire intestinal epithelium.  
 The sympathetic nervous system (SNS), one of two branches of the autonomic nervous system 
(ANS), innervates the intestinal epithelium. Data has shown that the SNS may play a role in CBC stem 
cell proliferation. Specifically, our laboratory has found that surgical sympathectomy increases intestinal 
epithelial crypt cell proliferation in rats (Davis et al., 2016). Others have also documented changes in 
crypt cell proliferation after partial ablation of the SNS nerves innervating the small intestine (Tutton & 
Helme, 1974). Despite these data demonstrating that the SNS is involved in regulating proliferation of 
crypt cells, it is not known if the SNS directly influences proliferation of the CBC stem cells themselves. 
The alpha2A adrenoreceptor (α2A-AR), a receptor subtype that binds the primary SNS neurotransmitter 
norepinephrine (NE) (Jacobowitz, 1965), has been localized within the intestinal epithelium, including in 
the crypt cells (Paris et al., 1990). It is not known, though, whether this receptor is expressed by the CBC 
stem cells, providing a molecular mechanism for direct SNS influence. Thus, we hypothesized that: 1) 
α2A-AR mRNA is expressed in CBC stem cells and 2) application of NE to intestinal epithelial organoids 
will alter proliferation rate of intestinal epithelial cells compared to untreated controls. In order to test 
these hypotheses, we isolated CBC intestinal epithelial stem cells from mice and measured the gene 
expression of α2A-AR. We compared these mRNA levels of other crypt cells from the same mice in order 
to evaluate expression of the α2A-AR between intestinal epithelial cell populations. In a separate 
experiment, crypts were isolated from mice and grown into functioning intestinal epithelial organoids in 
order to test the proliferation of intestinal epithelial crypt cells in response to NE application. Together, 
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these experiments evaluated SNS influence on intestinal epithelial stem cell proliferation, which 
contributes to current knowledge of neural control of stem cells.  
5.3 Materials and methods 
Animal housing 
 Lgr5-GFP (B6.129P2-Lgr5tm1(cre/ERT2)Cle/J; The Jackson Laboratory) and C57BL/6J mice 
were single-housed in shoeboxcages. Animals were maintained on a 12:12 light:dark cycle with ad 
libitum access to food (Teklad 22/5 Rodent Diet 8640 (Envigo, Madison, WI) and tap water. All 
procedures were approved by the Institutional Animal Care and Use Committee of the University of 
Illinois Urbana-Champaign.  
Crypt isolation 
 Small intestinal crypts were isolated from adult Lgr5-GFP and wild-type mice using a previously 
published protocol (Sato & Clevers, 2013). Briefly, mice were euthanized using decapitation under 
isoflurane (Phoenix, St. Joseph, MO). An incision was made at the base of the abdomen and extended up 
the sides to open the body cavity. The small intestine was located and removed, cutting at the level of the 
pyloric sphincter and the ileocecal sphincter. The small intestine was then cut into 10cm-long segments. 
An 18-gauge needle and syringe were used to flush the intestinal segments with ice-cold 1X phosphate-
buffered saline (PBS) (Lonza, Walkersville, MD). The segments were then cut open longitudinally and 
scraped with glass coverslips to remove the villi. Sections were further cut into 2-4 mm fragments. The 
fragments were placed in a 1X PBS-filled 50 mL Falcon tube and washed by inverting the tube at least 10 
times. The PBS was then removed and 30 mL Crypt Isolation Buffer (Promega, Madison, WI) was added 
to each tube and rocked for 30 minutes at 4°C. Samples were washed again with 1X PBS and then passed 
through a 70-µm cell strainer (Corning, Tewksbury, MA) and collected into 1% BSA-coated (Sigma-
Aldrich, St. Louis, MO) 50 mL Falcon tube. Samples were centrifuged at 300 x g for 10 minutes at 4°C.  
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Single cell dissociation 
 After centrifugation, samples were re-suspended with single cell dissociation medium prepared as 
described in a previously published protocol (Sato & Clevers, 2013). The samples were passed through a 
40-µm-cell strainer followed by a 20-µm cell strainer (PluriSelect, Leipzig, Germany). The cells were re-
suspended in basal culture medium as described in a previously published primary cell culture protocol 
(Sato & Clevers, 2013). The samples were centrifuged twice at 300 x g for 5 minutes, and then re-
suspended with single cell dissociation medium.  
Flow cytometry 
 The isolated crypt cells were prepared for flow cytometry and FACS as described in a previously 
published protocol (Sato & Clevers, 2013). Briefly, dead cells were excluded using propidium iodide and 
intestinal crypt cell populations were sorted using a BD FACS ARIA II. Results were analyzed using a 
BD LSR II. The analyzed cells had a green fluorescent protein (GFP) tag on the Lgr5 receptor, which are 
highly expressed in CBC stem cells. Samples were sorted into two populations: high GFP expression 
(CBC stem cells) and low GFP expression (crypt cells other than CBC stem cells, including the Paneth 
and transit amplifying cells). 
RNA isolation 
 RNA was extracted from each isolated cell population using the commercially available RNeasy 
Mini Kit (Qiagen, Valencia, CA). The RNA concentration was measured using a Nanodrop ND-1000 
Spectrophotometer.  
cDNA synthesis 
 The isolated RNA was amplified using a commercially available iScript cDNA Synthesis Kit 
following manufacturer’s instructions (Bio-Rad, Hercules, CA). Samples were incubated in the PTC-100 
Programmable Thermal Controller for 5 minutes at 25°C, 30 minutes at 42°C, then 5 minutes at 85°C.  
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Quantitative real-time PCR (qRT-PCR) 
 Alpha2A-AR mRNA expression was quantified by quantitative real time-PCR per manufacturer’s 
instructions of the commercially available Taqman kit (Applied Systems, Foster City, CA). PCR Reaction 
Mix was made using Taqman Universal PCR Master Mix, Taqman Gene Expression Assay, and cDNA 
template + H2O. Expression of the α2A-AR was determined by the TaqMan probe and measured in the 
Applied Biosystems 7900HT Fast Real-Time PCR System. The expression of GAPDH was utilized a 
control. Each cell population was plated in triplicate. The following Taqman probes were used: α2A-AR: 
Mm00845383_S1 and GAPDH: Mm99999915_g1. 
Organoid growth 
 A wild-type mouse was euthanized and intestinal epithelial crypts were isolated using the 
procedures previously described. After crypts were centrifuged for the final time, the supernatant was 
removed and crypts were re-suspended in Matrigel (Corning Inc., Corning, NY) and plated onto a pre-
warmed 24-well plate. Matrigel-crypt mix was applied to the center of each well and then allowed to 
solidify for 10 minutes in a 37°C incubator. Once the Matrigel solidified, 500 µL of IntestiCult Organoid 
Growth Medium (StemCell Technologies, Cambridge, MA) was added per well. Media were changed 
every 3 days and cells were split after 7 days.  
Organoid treatment with norepinephrine  
 After ten days of growth, organoids received one of three treatments: 1 µM norepinephrine, 10 
µM norepinephrine, or a sterile deionized water vehicle control. The drugs were made from 
norepinephrine bitartrate salt (Sigma Aldrich, St. Louis, MO) dissolved in deionized water. At 0h, 2h, 4h 
and 6h after administration of the respective drug treatment; proliferation was assayed using the 
CyQUANT NF Cell Proliferation Assay Kit (Thermo-Fischer, Austin, TX). One hour before the desired 
time point, a dye binding solution was added in order to bind the cellular DNA. The fluorescence 
intensity of each of the samples was measured using a Monochromator based absorbance 96 and 384-well 
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plate reader with excitation at ~485 nm and emission detection at ~530 nm. The higher the intensity of the 
fluorescence, the more DNA is bound indicating higher numbers of cells.  
Data analysis 
 Results were expressed as mean ± SEM. Gene expression for α2A-AR was analyzed using 
Student’s t-test using Number Crunching Statistical Software (NCSS). Proliferation was analyzed using 
one-way analyses of variance (ANOVA) using NCSS. Each time point of the experiment was analyzed 
independently and not compared across time points because different cells are used at each time point. 
Assumptions of normality, homogeneity of variance, and independence were met. Tukey-Kramer post 
hoc analysis was utilized where appropriate. Differences between treatments were considered statistically 
significant if p<0.05.  
5.4 Results 
Alpha2A adrenoreceptor mRNA expression 
 Alpha2A adrenoreceptor mRNA is expressed in CBC stem cells (Fig. 12). Although there was no 
significant difference in α2A-AR mRNA between the CBC stem cells and the other crypt cells (not 
including CBC stem cells), there is a trend toward increased α2A-AR mRNA expression in the CBC stem 
cells compared to the other crypt cells (Fig. 12; p = 0.06). Further, we also confirmed the expression of 
alpha2A adrenoreceptor mRNA in a separate population of crypt cells that were not divided into different 
cell types (Fig. 13). 
Organoid response to the addition of norepinephrine  
 Application of NE significantly decreased the proliferation rate of intestinal epithelial organoids 
at the 2-hour time point (Fig. 14; p<.05). No other time points showed a significant change in the 
proliferation rate.  
5.5 Discussion 
 Our data revealed that CBC stem cells express α2A-AR mRNA and that intestinal epithelial 
organoids in vitro decrease proliferation in response to NE. Together, these experiments demonstrate a 
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mechanism through which the SNS may be directly influencing intestinal epithelial stem cell 
proliferation.  
 When we investigated the expression of α2A-AR mRNA in all crypt cells, we found greater 
expression of α2A-AR in the stem cells compared with other crypt cells. This finding suggests that the 
SNS may have a greater influence on the stem cells through this receptor when compared with other crypt 
cells. Further, a low (1µM) dose of NE decreased proliferation of organoids 2h after application. These 
data suggest that an increase in SNS influence may lead to a decrease in proliferation rate in the intestinal 
epithelial cells, perhaps through α2A-AR signaling. Since α2A-ARs are typically defined as inhibitory 
receptors, activating this receptor with NE would likely suppress proliferation. This idea is consistent 
with our results showing that intestinal epithelial organoids decrease proliferation in response to NE. 
 In a separate study, our laboratory has also demonstrated that the in vivo denervation of the SNS 
in rats leads to an increase in intestinal epithelial cell proliferation rate (Davis et al., 2016). This finding 
complements the present in vitro data from the current study because it suggests that decrease in SNS 
influence leads to an increase in proliferation of intestinal epithelial crypt cells.  
 Our data reveal interesting trends with respect to the time points and concentration of NE 
application. After addition of NE to intestinal epithelial organoids, we see a significant decrease in 
proliferation at the 2h time point. However, there was no significant difference in proliferation at the 4h 
or 6h time points. It can be inferred that a significant decrease in proliferation was seen at the 2h time 
point and not the 4h or 6h time points because neurotransmitters have a short reaction time (Straub et al., 
2006). Although normally this reaction time is within seconds of NE application, it takes time for an 
effect to take place. Signal transduction and activation of cellular pathways involved in decreasing cell 
proliferation take time to act. Additionally, the time for cell number to significantly decrease requires 
time. Normally, the intestinal epithelial tissue compensates for cell loss by proliferating, thus the number 
of cells should remain the same. This trend is displayed in Figure 14, with each of the control populations 
remaining around a similar value. At the 4h and 6h time points, the organoids have had enough time to 
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recover population size after the decrease in proliferation. This is demonstrated by the lack of significant 
differences in organoid cell number at these time points. In order to further explore the duration of NE’s 
effect on organoid proliferation, shorter time points can be investigated in future experiments.  
 Another interesting finding showed that only the application of the 1 µM concentration of NE 
lead to a significant decrease in proliferation, whereas the 10 µM concentration of NE did not. This may 
be explained by the fact that there are only a limited number of receptors available for the NE to bind, 
meaning that a higher concentration of NE does not necessarily yield a larger suppression of proliferation. 
This trend can be further explored with more trials that utilize multiple different concentrations of NE.  
 We would like to continue to pursue research on SNS influence of CBC stem cell proliferation by 
studying intracellular signaling downstream of alpha2A adrenoreceptor activation. The α2A-AR is a G-
protein receptor that has been linked to the inhibition of cAMP production (Schaak et al., 2000). 
Inhibition of cAMP production can in turn alter the MAPK pathway, which is linked to regulation of 
proliferation (Schaak et al., 2000). By understanding the molecular mechanism underlying our data 
showing changes in proliferation rate, it may be possible to manipulate the pathway in order to alter CBC 
stem cell proliferation for therapeutic purposes.  
5.6 Conclusions 
 Our data support a role for direct neural control of intestinal epithelial stem cells, a topic which 
has not yet been extensively explored in existing scientific literature. By continuing to evaluate the effects 
of the SNS on CBC stem cell proliferation, we can better understand how changes in neural function can 
alter our intestine, further establishing the gut-brain axis.  
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5.7 Figures and captions 
Figure 12 
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Figure 12. Comparison of α2A-AR relative mRNA expression between CBC stem cells and other 
crypt cells.  
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Figure 13 
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Figure 13. α2A-AR relative mRNA expression in crypt cells.  
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Figure 14 
Figure 14. Proliferative response to the addition of either a low or high dose of norepinephrine to 
organoids represented as percent of control.  
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PART II: EFFECT OF NOREPINEPHRINE ON INTESTINAL EPITHELIAL CRYPT CELL 
PROLIFERATION   
 
5.8 Abstract 
The sympathetic nervous system (SNS) has been implicated in modulating the intestinal epithelial 
cell proliferation, as interruption of the SNS nerves to the intestine alters proliferation. Recent data has 
suggested that this phenomenon is mediated by a direct effect, as 1.) SNS neurotransmitter receptors are 
localized on intestinal epithelial stem and progenitor cells and 2.) intestinal epithelial organoids show 
decreased expression of cyclin D1, a gene necessary for cell cycle progression, in response to 
norepinephrine (NE) in vitro. Thus, we hypothesized that application of NE would decrease intestinal 
epithelial crypt proliferation in vitro. To test this, small intestinal crypts were isolated from adult male 
wild-type mice (n = 6) and cultured overnight. Crypts were treated with NE (0.1 µM or 1 µM) or a vehicle 
control. Proliferation was quantified using the CyQUANT Direct Cell Proliferation Assay Kit at 0h, 2h, 
4h, 12h, and 24h. Results demonstrated no significant differences of NE on crypt proliferation compared 
to controls. Although these results do not support a direct effect of the SNS on intestinal epithelial cell 
proliferation, further investigation is necessary to determine the nuances of what may be a subtle 
modulation of tissue turnover by the SNS. 
5.9 Introduction 
 The sympathetic nervous system (SNS) participates in control of peripheral organs and tissues, 
including the intestinal epithelium. SNS nerves innervate the intestinal epithelium (Jacobowitz, 1965) and 
control aspects of intestinal epithelial function, such as fluid transport (Greenwood et al., 1987). In 
addition, the SNS has been implicated in direct control of intestinal epithelial tissue turnover, as it is well-
established that surgical or chemical denervation of the SNS nerves to the intestine alters intestinal 
epithelial crypt cell proliferation (Tutton & Helme, 1974; Lachat & Goncalves, 1978; Kennedy et al., 
1983; Callaghan, 1991). More recently, there is emerging evidence from our laboratory that this effect 
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may be direct, involving sympathetic neurotransmitters binding to receptors directly localized on 
intestinal epithelial cells to affect proliferation downstream (Davis et al., 2018). Specifically, we have 
shown that the SNS-associated 𝛼2A-adrenoreceptor is expressed in proliferating cells of the intestinal 
epithelium, including the stem cells and the transit amplifying progenitor cells (Davis et al., 2018). We 
have also demonstrated that norepinephrine decreases Cyclin D1 in intestinal epithelial organoids in vitro 
(Davis et al., 2018). Cyclin D1 is a key cell cycle gene that is critical for the progression from G1 to S 
phase, and is rate limiting in proliferation (Ohtsubo & Roberts, 1993; Quelle et al., 1993; Albanese et al., 
1995; Watanabe et al., 1996; Resnitzky, 1997; Joyce et al., 1999). Therefore, it is likely that NE-induced 
changes in Cyclin D1 causes downstream changes in intestinal epithelial cell proliferation, further 
supported by evidence of NE-induced changes in proliferation in other cell types (Cruise et al., 1985; 
Geloen et al., 1988; Bronnikov et al., 1992; Oben et al., 2003b; Liu et al., 2014b; Liu et al., 2017). Thus, 
we hypothesized that NE would decrease intestinal epithelial organoid proliferation in vitro compared 
with controls.  
5.10 Materials and methods  
Animals  
Male wild type (C57BL/6J; n = 6) mice at 2 months of age (Jackson Laboratory, Bar Harbor, 
ME) were used. Animals were group housed in shoebox cages and maintained with ad libitum access to 
tap water and laboratory chow (Teklad 22/5, Envigo, Madison, WI) on a 12:12 light:dark cycle (lights on 
0700) in a climate-controlled room (temperature = 21±2°C and humidity = 50±10%).  
Crypt isolation and culture 
Small intestinal crypts were isolated as previously described (Sato & Clevers, 2013; Zhou et al., 
2018). Briefly, the animals were anesthetized under 3% isoflurane at 1.5L/min in an anesthesia induction 
chamber and then decapitated. The entire small intestine was harvested, opened longitudinally and 
washed with cold 1x PBS to remove luminal contents. The villi were scraped off with a coverslip. Villi 
from the wild type mice were collected into a falcon tube, and centrifuged at 300 g at 4°C for 5 min. The 
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supernatant was removed and the pellet containing the villus cells was immediately stored at -80°C to 
await processing. The remaining intestinal tissue was cut into 2-4 mm pieces with scissors and washed 5-
10 times with cold 1x PBS until the supernatant was almost clear. Tissue fragments were incubated with 2 
mM EDTA (Fisher Scientific, Pittsburgh, PA) and gently rocked at 4°C for 30 min. After removal of 
EDTA, tissue fragments were washed with 1x PBS 3 times. The supernatant was then collected and 
passed through a 70-um cell strainer (Corning, Corning, NY) and centrifuged at 300 g at 4°C for 5 min. 
The cell pellet was resuspended with basal culture medium [Advanced DMEM/F-12 Medium (Gibco, 
Grand Island, NY) containing 2 mM GlutaMax (Gibco, Grand Island, NY), 10 mM HEPES (Gibco, 
Grand Island, NY) and 100 U/mL Penicillin-Streptomycin (Gibco, Grand Island, NY)] and centrifuged at 
300 g 4°C for 5 min. After centrifugation, the supernatant was removed and isolated crypts were 
embedded in Matrigel at 170 crypts/8.5 µL and seeded in six replicates a on a pre-warmed 96-well costar 
clear bottom black plate (Corning, Tewkstar, MA). The matrigel was allowed to solidify for 10 minutes 
without media in a 37°C incubator and was then incubated in IntestiCult Organoid Growth Medium 
(StemCell Technologies, Cambridge, MA) at 100 per well. Crypts were grown overnight before cell 
proliferation experiments were begun.  
Cell proliferation measurements  
 For determination of cell proliferation in response to norepinephrine, crypts received one of 3 
treatments: 1 µM or 0.1 µM norepinephrine (A0937, Sigma Aldrich, St. Louis, MO) or a vehicle control. 
Differences between treatments were evaluated in different sets of cells at one of five time points: 0h, 2h, 
4h, 6h, or 24h. Proliferation was assayed using the CyQUANT Direct Cell Proliferation Assay Kit 
(Thermo-Fischer, Austin, TX) according to the manufacturer’s instructions. Fluorescence intensity at 
485 nm excitation and 528 nm emission was recorded using a Synergy HT BioTek microplate reader.  
Data analysis  
All variables were analyzed using Number Crunching Statistical Software (NCSS LLC, 
Kaysville, UT). Data were expressed as fold change compared to control, and are expressed as mean fold 
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change ± SEM. One-way ANOVAs were used to detect differences between treatments at individual time 
points. Assumptions of normality, homogeneity of variance, and independence were met. Differences 
were considered to be statistically significant at p < 0.05.  
5.11 Results 
 There was no effect of NE on intestinal epithelial crypt proliferation in vitro compared to controls 
at 0h, 2h, 4h, 12h, or 24h. (Fig. 15A-E).  
5.12 Discussion 
 This study investigated the effect of the major sympathetic neurotransmitter, NE, on intestinal 
epithelial crypt cell proliferation in vitro. We hypothesized that NE would decrease proliferation 
compared with controls. However, we found no effect of NE on proliferation compared with controls at 
0h, 2h, 4h, 12h, or 24h.  
 In contrast to the present results, we have previously shown that NE decreases cyclin D1 in 
intestinal epithelial organoids in vitro (Davis et al., 2018). This decrease in cyclin D1 would typically 
accompany a corresponding decrease in proliferation. Cyclin D1 is required for the G1/S transition in the 
cell cycle, and subsequently participates in determining a cell’s proliferative fate (Fu et al., 2004). In 
other cell types, adrenergic signaling alters cyclin D1 and proliferation (Karkoulias & Flordellis, 2007). In 
addition, a suppression of cyclin D1 in intestinal epithelial organoids by another autonomic 
neurotransmitter, acetylcholine, is accompanied by suppression of growth by cholinergic signaling 
(Takahashi et al., 2014; Davis et al., 2018). Although there is evidence in support of NE-driven 
modulation of intestinal epithelial cell proliferation, our results showed no effect.  
 A possible explanation for the discrepancy in our results is the increased variability in measuring 
proliferation compared with measuring gene expression. Accuracy of measuring crypt cell proliferation is 
limited compared with traditional cell culture systems because we are unable to plate exactly the same 
number of cells in each well at the start of the experiment. Although an equal number of crypts are plated 
per well, the total number of cells in each crypt varies. This inability to control starting number of cells 
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introduces deviations that will persist to the endpoint proliferation measurements. Therefore, the modest 
effect of NE on cyclin D1/proliferation may be masked by variability when measuring proliferation, but 
revealed when cyclin D1 gene expression per cell is tightly controlled in qPCR by the use of a 
housekeeping gene. Thus, careful attention to details regarding use of proliferation assays and further 
exploration of this possible effect using improved techniques and expanded conditions is merited.  
  If there is indeed a direct effect of the SNS on intestinal epithelial cell proliferation under 
homeostatic conditions, it is unlikely to be a robust modulator of proliferation, but instead a system that 
fine tunes proliferation according to subtle fluctuations in sympathetic tone. This proves to be a 
challenging phenomenon to study, but persistence will allow us to unravel the complex interactions 
between the SNS and somatic stem cells.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
	
	
77 
5.13 Figure and caption 
Figure 1 
 
 
     
Figure 1. Effect of norepinephrine on proliferation in intestinal epithelial crypts. NE has no effect on 
intestinal epithelial crypt proliferation at (A) 0h, (B) 2h, (C) 4h, (D) 12h, or (E) 24h. Results expressed as 
Mean Fold Change +/- SEM.  
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CHAPTER 6: LONG-TERM EFFECT OF PARASYMPATHETIC OR SYMPATHETIC 
DENERVATION ON INTESTINAL EPITHELIAL CELL PROLIFERATION AND APOPTOSIS  
 
(Published in Experimental Biology and Medicine; Citation: Davis EA, Washington MC, Yaniz ER*, 
Phillips H, Sayegh AI, & Dailey MJ. (2017). Long-term effect of parasympathetic or sympathetic 
denervation on intestinal epithelial cell proliferation and apoptosis. Experimental Biology and 
Medicine, 242(15), 1499-1507.) 
*Undergraduate mentee of EAD 
 
6.1 Abstract 
 Intestinal epithelial tissue is constantly regenerated as a means to maintain proper tissue function. 
Previous studies have demonstrated that denervation of the parasympathetic (PNS) or sympathetic (SNS) 
nervous system to the intestine alters this process. However, results are inconsistent between studies, 
showing both increases and decreases in proliferation after denervation of the PNS or SNS. The effect 
appears to correlate with 1) the timing post-denervation, 2) denervation-induced changes in food intake, 
3) the denervation technique used, and 4) which intestinal segment is investigated. Thus, we proposed that 
PNS or SNS denervation does not have an effect on intestinal epithelial regeneration when you 1) 
evaluate denervation after long-term denervation, 2) control for post-surgical changes in food intake, 3) 
use minimally invasive surgical techniques and 4) include a segmental analysis. To test this, adult male 
Sprague Dawley rats underwent PNS denervation via subdiaphragmatic vagotomy, SNS denervation via 
celiacomesenteric ganglionectomy, a PNS denervation sham surgery, or an SNS denervation sham 
surgery. Sham surgery ad libitum fed groups and sham surgery pair fed groups were used to control for 
surgically-induced changes in food intake. Three weeks post-surgery, animals were euthanized and tissue 
from the duodenum, jejunum, and ileum was excised and immunohistochemically processed to visualize 
indicators of proliferation (bromodeoxyuridine-positive cells) and apoptosis (caspase-3-positive cells). 
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Results showed no differences between groups in proliferation, apoptosis, or total cell number in any 
intestinal segment. These results suggest that PNS or SNS denervation does not have a significant long-
term effect on intestinal epithelial turnover. Thus, intestinal epithelial regeneration is able to recover after 
ANS injury.  
6.2 Introduction 
 The autonomic nervous system (ANS) is implicated in the control of tissue regeneration. A focus 
of prior research has been on the ANS control of intestinal epithelial cell turnover, as it is among the most 
rapidly regenerating tissues of the body (van der Flier & Clevers, 2009). Ablation of either branch of the 
ANS, the parasympathetic (PNS) or sympathetic (SNS), alters intestinal epithelial cell proliferation as 
indicated by a change in the mitotic index (Tutton & Helme, 1974; Musso et al., 1975a; Tsibulevskii & 
Orlova, 1976; Lachat & Goncalves, 1978; Kennedy et al., 1983; Callaghan, 1991) and length of the cell 
cycle (Tutton & Helme, 1974). These data, though, are inconsistent across studies. After PNS 
denervation, the direction of fluctuation in proliferation appears to be time dependent. At early time 
points post-denervation, intestinal epithelial cell proliferation is decreased (Musso et al., 1975a; Lachat & 
Goncalves, 1978). The early decrease in proliferation may be due to a concomitant decrease in food 
intake, which is known to decrease intestinal epithelial cell proliferation independent of an ANS influence 
(Brown et al., 1963). At later time points post-PNS denervation, proliferation has been shown to be 
increased (Tsibulevskii & Orlova, 1976; Callaghan, 1991) or equal to that of control animals (Bejar et al., 
1968; Musso et al., 1975a), perhaps demonstrating a recovery over time (Musso et al., 1975a). Thus, 
these changes may be indirectly driven by changes in food intake after PNS denervation, rather than a 
direct influence of the loss of the PNS. Sympathetic denervation also exhibits varied results for 
regeneration of this tissue. The effect on intestinal epithelial proliferation appears to correlate with the 
extent of denervation induced by specific SNS denervation techniques and which intestinal segment 
(duodenum, jejunum or ileum) is investigated. A long-term decrease in proliferation is seen after extreme 
techniques (e.g., chemical sympathectomy) (Tutton & Helme, 1974; Kennedy et al., 1983). However, a 
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more focused surgical denervation targeting the celiacomesenteric nerves that innervate the intestine 
results in no change in proliferation along most of the proximal to distal axis of the intestine (Tutton & 
Helme, 1974; Musso et al., 1975a; Lachat & Goncalves, 1978; Callaghan, 1991). Thus, we propose that 
PNS or SNS denervation does not have a long-term effect on intestinal epithelial regeneration when you 
control for post-surgical changes in food intake and use minimally invasive surgical techniques. A 
recovery of function after long-term ANS denervation is seen in processes related to intestinal function, 
including motility (Andrews & Bingham, 1990), food intake (Rezek et al., 1975; Schneider et al., 1976) 
and blood flow (Mackie & Turner, 1971). Recovery is also seen in aspects of tissue regeneration in other 
organs, including the liver (Kato & Shimazu, 1983; Tanaka et al., 1987) and the pancreas (Edvell & 
Lindstrom, 1998). Thus, it is possible that intestinal epithelial turnover exhibits this same pattern of 
recovery after a long-term loss of ANS input. In order to test this, male Sprague Dawley rats were 
subjected to PNS denervation or SNS denervation. To control for surgical effects, we included sham 
surgical control conditions for each surgical procedure. To control for the change in food intake that often 
occurs post-ANS denervation, we included a pair fed sham surgical group for both the PNS and the SNS 
denervation. We euthanized the animals 3 wks post-surgery because this is generally regarded to be a 
minimum time for recovery of other intestinal physiological processes after ANS denervation (Mackie & 
Turner, 1971; Rezek et al., 1975; Schneider et al., 1976; Andrews & Bingham, 1990). We have defined 
this 3 wk time point as ‘long-term’ based on the timeline of these other recovery processes. We collected 
intestinal tissue from three intestinal segments (duodenum, jejunum and ileum) and 
immunohistochemically processed the tissue to measure levels of proliferation, apoptosis, and total crypt 
and villus cell numbers. This study contributes to the basic understanding of autonomic influence on 
tissue regeneration.  
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6.3 Materials and methods 
Animals 
 All procedures were approved by the Institutional Animal Care and Use Committee at the 
University of Illinois at Urbana-Champaign. Male Sprague-Dawley rats (n = 56; Harlan, Hsd:Sprague 
Dawley® SD®; 225-275g). Upon arrival, the animals were single-housed in tub cages with ad libitum 
access to chow diet (Harlan 8640, Harlan Sprague Dawley Inc, Indianapolis, IN), tap water, and a ceramic 
bowl for enrichment. They were maintained on a 12:12 light:dark cycle (lights on 0700h, lights off 
1900h). Food intake and body weight were measured daily at 1500h. The animals acclimated to these 
conditions for 1 wk prior to surgery.  
Surgical procedures  
 Animals underwent an overnight fast prior to undergoing surgery. Animals were given an 
anesthesia mixture (0.1mL/100g body weight intramuscularly containing the following: 100mg/mL 
ketamine (Henry Schein Animal Health, Dublin OH), 100mg/mL xylazine (Akorn, Decatur, IL), 
10mg/mL Acepromazine Maleate (Boehringer Ingelheim, St. Joseph, MO) in 0.9% sterile saline (Henry 
Schein Animal Health, Dublin, OH). For PNS denervation (n = 12) the body cavity was opened with a 
midline incision of the skin. The dorsal and ventral branches of the subdiaphragmatic vagus were located 
by blunt dissection of the overlying tissues, isolated, and ligated above the hepatic, celiac, and accessory 
celiac branches. Each nerve trunk was cut distal to the ligature and above the vagal branches, producing 
total vagal transection. The portion of the nerve distal to the cut was carefully stripped away from the 
underlying esophagus. For sham vagotomy surgeries (n=15), the esophagus, stomach, dorsal and ventral 
branches of the subdiaphragmatic vagus were manipulated, but the vagi were left intact. These procedures 
were performed as previously described (Kalia & Sullivan, 1982; Yox et al., 1991; Sullivan et al., 2007; 
Brown et al., 2011; Hunt et al., 2012). For sympathetic denervation (n=11), the body cavity was opened 
with a midline incision of the skin. The left kidney, cranial mesenteric artery and celiac artery were 
exposed by blunt dissection of the overlying tissues, and the celiac and mesenteric ganglia were located 
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between the arteries and were removed under 40× magnification using jeweler's scissors and forceps as 
previously described (Brown et al., 2011; Hunt et al., 2012; Wright et al., 2012). The removal was made 
to ensure no severing of other nerve branches (e.g., the celiac branch of the vagus nerve) that run in close 
proximity to the ganglia. Sham celiacomesenteric ganglionectomy surgeries (n=14) were performed by 
manipulating the tissue without removal of the celiac or mesenteric ganglia. Before closure of the surgical 
sites, 0.25% bupivacaine (Hospira, Lake Forest, IL) was applied to the incision site at a dose of 2mg/kg as 
a local anesthetic. The animals received a dose of Rimadyl (Pfizer, New York, NY) at 5mg/kg 
subcutaneously while still under anesthesia as an analgesic. Two more doses of Rimadyl at 5mg/kg were 
administered subcutaneously for two days after surgery.  
Feeding protocol 
 After a 1 wk recovery period, animals either had ad libitum access to food or were pair fed during 
a 2 wk feeding period. All animals that underwent PNS or SNS surgical denervation, had ad libitum 
access to chow diet throughout the 2 wk feeding period. PNS or SNS sham surgery animals were divided 
into two groups based on average body weight: ad libitum access to chow or pair fed chow in equal 
average kcal to that eaten by the denervated rats. These animals underwent a sham surgery, and were then 
provided the same amount of food consumed by the corresponding denervated group. Thus, the six 
groups were 1) PNS denervated, 2) PNS pair fed sham, 3) PNS ad lib fed sham, 4) SNS denervated, 5) 
SNS pair fed sham and 6) SNS ad lib fed sham.  
Euthanasia 
 After the 2 wk feeding period, animals had their food removed at the beginning of the light cycle 
and continued to be fasted for the remaining 12h prior to euthanization at the beginning of the dark cycle. 
This fasting period was sufficient minimize the amount of food present in the intestine at the time of 
euthanization. At 6h prior to euthanization, 5-bromo-2’-deoxyuridine (BrdU; Sigma-Aldrich, St. Louis, 
MO) injections were administered IP at 50mg/kg body weight in a volume of 1.5mL sterile deionized 
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water. Animals were then euthanized under isoflurane (Henry Schein Animal Health, Dublin, OH) 
anesthesia by decapitation. Tissue was collected from the duodenum, jejunum and ileum.  
Tissue processing 
 Intestinal segments were flushed with 1X phosphate buffered saline (PBS) and filled with 4% 
paraformaldehyde (PFA; Sigma-Aldrich, St. Louis, MO) for 12h at 4°C and then stored in 1X PBS at 4°C 
prior to paraffin embedding. Paraffin embedding was done in a Leica ASP300 Tissue Processor (Leica, 
Wetzlar Germany) and embedded using Paraplast tissue embedding media (Fisher Scientific, West Lawn, 
NJ). For slide preparation, sections were cut on a microtome at 5µm and then mounted on Superfrost™ 
Plus Microscope Slides (Fisher Scientific, Pittsburgh, PA).  
Immunohistochemistry: Proliferation  
 Tissue sections were deparaffinized in xylenes followed by a series of graded ethanols, then 
rinsed in deionized water. Antigen retrieval was performed by immersing the slides in sodium citrate 
buffer (Sodium Citrate Hydrochloride, Fisher Scientific and Tween 20, Sigma- Aldrich, Germany, pH 
6.0) for 20 min in a water bath at 95°C, then allowed to cool while still immersed in the sodium citrate 
buffer solution for 30 min at RT. Slides were rinsed between each step in 1X PBS. Slides were incubated 
in blocking solution containing 0.3% Triton-X (Sigma-Aldrich, St. Louis, MO) and 3% Normal Donkey 
Serum (JacksonImmunoResearch, West Grove, PA) diluted in 1X PBS at RT for 1h. Sections were then 
incubated overnight in an anti-BrdU primary antibody (1:1000, ab1893, Abcam, San Francisco, CA) 
diluted in the blocking solution. Sections were incubated in a donkey anti-sheep IgG H&L secondary 
antibody (1:500, ab6899, Abcam, San Francisco, CA) diluted in 1X PBS for 1h at RT. Sections were then 
incubated in an avidin–biotin complex (Vectastain Elite reagents, Vector Labs, Burlingame, CA) for 1h at 
RT. A diaminobenzidine-hydrogen peroxidase reaction was performed using a substrate kit (SK-4100, 
Vector Laboratories, Burlingame, CA). Sections were counterstained in hematoxylin (Fisher HealthCare, 
Houston, TX) and dehydrated in a series of graded ethanols followed by xylenes. Slides were 
coverslipped with Permount mounting media (Fisher Scientific, Fair Lawn, NJ) and stored at RT.  
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Immunohistochemistry: Apoptosis  
 Slides were processed as described above with the following exceptions: Slides were incubated in 
the blocking solution for 1.5h at RT. The primary antibody used was an anti-caspase-3 antibody (1:2500, 
cat. no. 9662, Cell Signaling Technologies, Danvers, MA). After washing in PB, sections were incubated 
in donkey anti-rabbit IgG (711-065-152, Jackson ImmunoResearch, West Grove, PA) diluted in 1X PB 
for 1h at RT. Sections were then washed in 1X PB and processing continued as described above except 
that PB was used instead of PBS.  
Quantification  
 Intestinal tissue sections were visualized using a NanoZoomer Digital Pathology System 
(Hamamatsu, Hamamatsu City, Japan) using a 40x objective and NDP Scan software. Quantification was 
performed by visual inspection of the images on a desktop computer using NDP View 2 software by two 
individuals that were blinded to the treatments. Nine crypts or villi per section were chosen based on 
intact morphology of the intestine. Total crypt cell number, BrdU-positive crypt cell number, proliferation 
ratio (defined as BrdU-positive crypt cell number divided by total crypt cell number), and crypt depth 
were determined from slides immunohistochemically processed for BrdU. Total villus cell number, 
caspase-3-positive villus cell number, apoptotic ratio (defined as caspase-3-positive villus cell number 
divided by total villus cell number), and villus height were determined from slides 
immunohistochemically processed for caspase-3.  
Statistical analysis 
 All variables were analyzed using Number Crunching Statistical Software (NCSS LLC, 
Kaysville, UT). Food intake and body weight were analyzed using separate two-way repeated measures 
analyses of variance (ANOVA; 3×13; treatment group × day) for PNS and SNS experiments. Measures of 
proliferation and apoptosis were analyzed using separate one-way ANOVA (treatment group) for each 
intestinal segment (duodenum, jejunum or ileum). Assumptions of normality, homogeneity of variance, 
 
	
	
88 
and independence were met. Tukey-Kramer post hoc analyses were utilized where appropriate. 
Differences among groups were considered statistically significant if p < 0.05. 
6.4 Results 
Food intake 
  Average 24h food intake (kcal) was decreased in PNS denervated and pair fed sham groups 
compared with ad lib fed sham animals on days 8 through 12 post-surgery (p < 0.05; Fig. 16A). There 
were no differences in average 24h food intake (kcal) between SNS denervated, ad lib fed sham, or pair 
fed sham animals at any time point (Fig. 16B).  
Body weight 
 Body weight was significantly different between all three PNS groups across all time points, with 
the lowest body weight seen in the PNS denervated animals and the highest in the ad lib fed sham animals 
(p < 0.05; Fig. 17A). Body weight was increased in the SNS denervated animals compared with the ad lib 
fed sham animals only on day 20 post-surgery (p < 0.05; Fig. 17B).  
Effect of PNS denervation on proliferation 
 BrdU-positive cells (representative image, Fig. 18A) in the jejunum were increased in the PNS 
denervated animals compared with pair fed sham animals (p < 0.05, Fig. 18B), but PNS denervated and 
ad lib fed sham were not different from each other. There were no differences in the number of BrdU-
positive cells between the groups when the duodenum or ileum were analyzed (Fig. 18B). Proliferation 
ratio and total number of crypt cells were not different between the groups across all segments of the 
intestine (Figs. 18C&D).  
Effect of SNS denervation on proliferation 
 There were no differences between the groups in BrdU-positive cell number, proliferation ratio, 
or total crypt cell number in the duodenum, jejunum, or ileum (Figs. 19A-C).  
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Effect of PNS denervation on apoptosis 
 There were no differences between groups in caspase-3-positive (representative image, Fig. 20A) 
villus cell number, apoptotic ratio, or total number of villus cells (Figs. 20 
B-D) in the duodenum, jejunum, or ileum.  
Effect of SNS denervation on apoptosis 
 There were no differences between groups in caspase-3-positive villus cell number or 
proliferation ratio in the duodenum, jejunum, or ileum (Figs 21A&B). However, total crypt cell number 
was increased in the SNS denervated animals compared with pair fed sham animals (p < 0.05; Fig. 21C).  
6.5 Discussion 
 We found no differences in proliferation, apoptosis, crypt or villus cell number in the intestinal 
epithelium after long term PNS or SNS denervation (3 wks) compared to the sham control groups. These 
results coincide with those of others when the denervated groups are compared with sham surgical control 
animals at later time points post-denervation (Musso et al., 1975a; Lachat & Goncalves, 1978) and has 
been found in humans post-ANS denervation (Bejar et al., 1968; Hansen et al., 1978). It appears that the 
mechanisms controlling proliferation and apoptosis are able to recover post-denervation as has been 
found in other processes related to intestinal function [motility (Andrews & Bingham, 1990), food intake 
(Rezek et al., 1975; Schneider et al., 1976) and blood flow (Mackie & Turner, 1971)] and in aspects of 
tissue regeneration in other organs [liver (Kato & Shimazu, 1983; Tanaka et al., 1987) and the pancreas 
(Edvell & Lindstrom, 1998)]. Because cell turnover is vital in maintaining proper tissue function, these 
results are important in order to reveal possible implications of the use of ANS denervation in human 
medicine.  
 Previous research supports the idea that the direction of fluctuation in proliferation after PNS 
denervation appears to be time dependent. Within the first few days after PNS denervation, intestinal 
epithelial proliferation decreases, as measured in the rat ileum at four different post-denervation time 
points, including 6h, 1 day, 2 days, and 3 days (Musso et al., 1975a; Lachat & Goncalves, 1978). Several 
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groups demonstrate that proliferation increases 1 wk post-PNS denervation in the jejunum (Tsibulevskii 
& Orlova, 1976; Callaghan, 1991) and the ileum in rats (Callaghan, 1991). However, others suggest that 
there is no difference in the ileum compared to sham controls at 6 or 10 days post-denervation (Musso et 
al., 1975a). Despite these discrepancies in proliferation at early time points, human jejunal biopsies post-
PNS denervation have suggested that there is no change in intestinal proliferation 3 and 6 weeks post-
surgery (Bejar et al., 1968). Long-term studies in the rat did not measure proliferation specifically, but no 
histological changes were seen in the jejunum or ileum from 12 to 32 wks post-PNS denervation (Ellis & 
Pryse-Davies, 1967). Together, these studies suggest changes in proliferation at early time points after 
PNS denervation followed by eventual stabilization of proliferation. However, these studies did not 
control for surgically-driven decreases in food intake, a known influence on intestinal epithelial cell 
proliferation (Brown et al., 1963). The present study accounted for surgically-induced changes in food 
intake and still demonstrated recovery of intestinal epithelial proliferation after PNS denervation in all 
three intestinal segments.  
 The effect of SNS denervation on intestinal epithelial proliferation appears to correlate with the 
extent of denervation induced by specific denervation techniques. Chemical denervation techniques, 
which ablate sympathetic nerves globally, produce a long lasting decrease in proliferation (Tutton & 
Helme, 1974; Kennedy et al., 1983). However, more precise surgical denervations produce a short-term 
effect in the jejunum (Tutton & Helme, 1974; Callaghan, 1991) or no effect in the ileum (Musso et al., 
1975a; Lachat & Goncalves, 1978). As surgical rather than chemical denervation of the SNS is used in 
human medicine, we were interested in the effect of surgical SNS denervation (i.e., celiacomesenteric 
ganglionectomy) on intestinal epithelial turnover in each segment of the intestine. The present results 
revealed no differences in intestinal epithelial proliferation or apoptosis in the duodenum, jejunum or the 
ileum 3 wks post-SNS denervation. These results are similar to those of others using the same surgical 
approach (Musso et al., 1975a; Lachat & Goncalves, 1978). Thus, it appears that intestinal epithelial 
turnover may also recover after minimally-invasive surgical SNS denervation.  
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 Even though there was no difference in the proliferation or apoptosis of the intestinal epithelium 
in the denervated compared with the sham surgical control groups in any segment of the intestine, there 
was an effect of pair feeding on the proliferation of the intestinal epithelium within the jejunum post-PNS 
denervation. The decrease in proliferation in the pair fed group was seen even though at the time of 
euthanization, all three PNS groups were eating equal kilocalories of food. This may be the result of how 
these animals were fed each day. They were provided the same amount of food consumed by the 
corresponding denervated group at the same time every day and ate all of the food within a few hours, 
instead of freely feeding throughout the day/night cycle. This may have conditioned the animals to 
anticipate and ingest food at regularly scheduled meals and set a circadian rhythm. We found that pair-
feeding within the jejunum decreased intestinal epithelial proliferation and that PNS denervation 
attenuated this decrease in proliferation. This difference is seen even though at the time of euthanization, 
all three groups were eating similar kilocalories of food. Meal feeding has been shown to alter the 
circadian rhythm of intestinal epithelial proliferation (Lakatua et al., 1983). Given that this only occurred 
in the PNS pair fed group and not the SNS pair fed group, there was likely an interaction between meal 
feeding and the amount (in kcals) provided over days or weeks. This is because the PNS denervated, and 
not the SNS denervated group, decreased their food intake post-surgery. Thus, only the PNS pair fed 
group was fed lesser kcals than they may have eaten ad libitum and less than the SNS pair fed group was 
eating. These data support the idea that the kcal amount of food alters intestinal epithelial proliferation 
and that there can be lasting effects of the amount of food eaten on the proliferative capacity of the 
intestinal epithelium (Brown et al., 1963; Mah et al., 2014; Beyaz et al., 2016).  
 Compensatory mechanisms occur after ANS denervation in order to reestablish intestinal function 
under a variety of conditions and include (1) an upregulation of gastrointestinal (GI) receptor expression, 
(2) compensation by the non-denervated ANS branch and (3) enteric nervous system modulation. For 
example, PNS denervation initially decreases intestinal motility (Ridolfi et al., 2009), a process which is 
heavily mediated by serotonin (Kendig & Grider, 2015). PNS denervation has also been shown to reduce 
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the amount of 5-HT-3 positive serotonergic nerve fibers in the GI tract (Glatzle et al., 2002). As gene 
expression of the serotonin receptor 5-HT-3 is upregulated in the intestinal epithelium, motility recovers 
(Tong et al., 2011). This restored motility can be blocked with administration of a 5-HT3 antagonist 
(Tong et al., 2011). Therefore, upregulation of serotonin receptors in the epithelium is thought to be 
driving the recovery of intestinal motility. Since serotonin receptors have also been found to be involved 
in intestinal epithelial proliferation, upregulation of the receptors after PNS denervation may contribute to 
the recovery of cell turnover (Gross et al., 2012; Dong et al., 2016). Changes in the specific primary 
neurotransmitter receptors of the denervated ANS branch are also likely to undergo changes to facilitate 
recovery of the intestinal epithelial turnover. PNS denervation upregulates the amount of muscarinic 
acetycholinergic gene expression in the stomach (Keshavarzian et al., 1990) and downregulates the 
expression in the small intestine (Higuchi et al., 1985). The intact branch of the ANS may also participate 
in the compensation to recover function after denervation. PNS denervation decreases the concentration 
of norepinephrine, the main SNS neurotransmitter, in the stomach (Graffner et al., 1985; Orloff et al., 
1985). Therefore, changes in aspects of both the denervated and intact branches of the ANS may be 
driving the recovery of function after ANS denervation. The enteric nervous system (ENS), a network of 
neurons intrinsic to the GI tract, modulates specific intestinal epithelial progenitors to control regeneration 
(Bjerknes & Cheng, 2001). Given that the ENS makes synaptic connections to both the PNS and the SNS 
(Costa et al., 2000), it is likely that the ENS may also contribute to the recovery of tissue regeneration 
after the loss of ANS input as it does in other intestinal functions (Nakao et al., 1998). Taken together, 
varied compensatory mechanisms after ANS denervation may collectively contribute to the recovery of 
intestinal function, including proliferation and apoptosis.  
 We found that the regenerative capacity of the intestinal epithelium is not chronically disrupted 
by denervation of either branch of the ANS. Our data support the narrative that compensatory 
mechanisms recover a variety of physiological functions to homeostatic levels after autonomic injury. 
This finding is important because autonomic denervation is currently utilized in human patients to treat a 
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variety of diseases. PNS denervation is used for the treatment of gastric ulcers (Olbe, 1994), and also may 
occur as a consequence of gastric bypass surgery (Okafor et al., 2015). SNS denervation is currently used 
to treat hyperhidrosis (Dumont et al., 2004), facial blushing (Girish et al., 2017), and a variety of other 
conditions (Hashmonai et al., 2016). New treatments involving autonomic denervation may also be 
implemented in the future for other diseases involving autonomic imbalance, such as rheumatoid arthritis 
(Koopman et al., 2011) or chronic pain (Xie et al., 2016). Disruptions to the intestinal epithelial turnover 
process as a side effect of ANS denervation procedures could result in improper intestinal epithelial 
function. For example, chronic decreases in proliferation might lead to mucosal atrophy, a severe 
reduction in absorptive surface area of the intestine. Mucosal atrophy can lead to intestinal failure, which 
causes diarrhea, malabsorption, and progressive malnutrition (Shaw et al., 2012). In contrast, chronic 
increases in proliferation may lead to increased epithelial cell numbers, resulting in excessive increases in 
nutrient absorption (Singh et al., 1972; Ferraris & Vinnakota, 1995). Uncontrolled increases in intestinal 
epithelial cell proliferation may also lead to the development of cancer (Krausova & Korinek, 2014). 
However, based on our findings that intestinal epithelial turnover is able to recover after autonomic 
injury, ANS denervation may be used as treatment for certain diseases without affecting intestinal 
epithelial tissue regeneration. 
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6.6 Figures and captions  
Figure 16 
 
Figure 16. Influence of PNS or SNS denervation on daily food intake. (A) Average daily food intake 
was decreased in PNS denervated animals and pair fed sham animals compared with ad lib fed sham 
surgical controls on days 8 through 12 post-surgery (p < 0.05; *). (B) SNS denervation did not 
significantly alter average daily food intake.  
 
 
 
 
 
 
 
 
 
 
95	
	
Figure 17 
 
Figure 17. Influence of PNS or SNS denervation on body weight. (A) Average body weight was 
decreased in PNS denervated animals and pair fed sham animals compared with ad lib fed sham animals 
across all time points (p < 0.05; *). Average body weight was decreased in PNS denervated animals 
compared with pair fed sham days across all time points (p < 0.05; #). (B) Average body weight of SNS 
denervated animals was increased compared with ad lib fed sham animals on day 20 post-surgery (p < 
0.05; *).  
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Figure 18 
 
 
Figure 18. Effect of PNS denervation on intestinal epithelial crypt cell proliferation. (A) Intestinal 
tissue immunohistochemically processed with an anti-BrdU antibody to visualize intestinal epithelial 
crypt cell proliferation. Tissue counterstained with hematoxylin. (B) Average proliferating crypt cell 
number in the jejunum was increased in PNS denervated animals compared with pair fed sham animals (p 
< 0.05). (C) There were no differences between groups in average proliferation ratio in the duodenum, 
jejunum, or ileum. (D) There were no differences between groups in average total crypt cell number in the 
duodenum, jejunum, or ileum.  
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Figure 19 
 
Figure 19. Effect of SNS denervation on intestinal epithelial crypt cell proliferation. (A) There were 
no differences between groups in average apoptotic villus cell number in the duodenum, jejunum, or 
ileum. (B) There were no differences between groups in average apoptotic ratio in the duodenum, 
jejunum, or ileum. (C) There were no differences between groups in average total crypt cell number in the 
duodenum, jejunum, or ileum.  
 
 
 
 
 
 
 
 
 
 
 
 
 
98	
	
Figure 20 
 
 
Figure 20. Effect of PNS denervation on intestinal epithelial cell apoptosis. (A) Intestinal tissue 
immunohistochemically processed with an anti-caspase 3 antibody to visualize intestinal epithelial cells 
undergoing apoptosis. (B) There were no differences between groups in average apoptotic villus cell 
number in the duodenum, jejunum, or ileum. (C) There were no differences between groups in average 
apoptotic ratio in the duodenum, jejunum, or ileum. (D) There were no differences between groups in 
average total villus cell number in the duodenum, jejunum, or ileum.  
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Figure 21 
 
 
Figure 21. Effect of SNS denervation on intestinal epithelial cell apoptosis. (A) There were no 
differences between groups in average apoptotic villus cell number in the duodenum, jejunum, or ileum. 
(B) There were no differences between groups in average apoptotic ratio in the duodenum, jejunum, or 
ileum. (C) Average total villus cell number was increased in SNS denervated animals compared with pair 
fed sham animals (p < 0.05). 
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6.8 Supplemental material: Brief discussion of surgical verification methodology  
 We collaborated with a laboratory that routinely performs both bilateral subdiaphragmatic 
vagotomies and celicaomesenteric ganglionectomies (Sullivan et al., 2007; Brown et al., 2011; Hunt et 
al., 2012; Wright et al., 2012). For vagotomy confirmation, we confirmed that during death, all 
vagotomized rats showed severely distended stomachs, which is an accepted verification of vagotomy 
(Sullivan et al., 2007).  Due to the expertise of the surgeon who routinely performs this procedure, we 
chose not to verify vagotomies using a second method. If desired, anatomical methods of verification 
include immediate hematoxylin and eosin (H&E) staining of removed vagal tissue and confirmed 
identification of a circular bundle of axons characteristic of the vagus nerve (Brown et al., 2011; Hunt et 
al., 2012; Wright et al., 2012). Furthermore, postmortem verification can be achieved by confirming a 
lack of the vagus nerve (Brown et al., 2011; Hunt et al., 2012; Wright et al., 2012).  Functional methods 
of vagotomy verification include measuring cumulative food intake in response to intraperitoneal 
administration of cholecystokinin, which fails to reduce food intake in vagotomized animals compared 
with sham surgeries (Hunt et al., 2012; Wright et al., 2012), or measurement of decreased gastric 
emptying by phenol red (Lee et al., 2012). 
 Celiacomesenteric ganglionectomies were verified by observation of increased defecation, which 
is indicative of increased gastric empyting and intestinal transit time (Rosa-e-Silva et al., 1996). We did 
not choose to further verify these surgeries due to the expertise of the surgeon, who routinely performs 
this procedure. If desired, additional methods of verification include immediate H&E staining of the 
removed tissue and confirmation of distinct neuronal tissue with extensive number of cell bodies that is 
characteristic of the celiacomesenteric ganglion (Brown et al., 2011; Hunt et al., 2012; Wright et al., 
2012).  Postmortem anatomical verification may include confirmation of the lack of a celiacomesenteric 
ganglion (Brown et al., 2011; Hunt et al., 2012) or immunohistochemical staining of intestinal 
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wholemounts that are absent of tyrosine hydroxylase staining, which is indicative of sympathetic 
denervation (Liu et al., 2015a).  
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CHAPTER 7: SUMMARY: A DIRECT EFFECT OF THE AUTONOMIC NERVOUS SYSTEM 
ON SOMATIC STEM CELL PROLIFERATION?  
 
7.1 Summary 
 Somatic stem cell proliferation is critical for maintaining tissue homeostasis through the 
regeneration of tissues. Multiple physiological systems modulate somatic stem cell proliferation by 
altering the rate of renewal, the number of cells produced, or the ratio of differentiated daughter cell 
types. All of these outcomes ultimately lead to functional changes in the tissue. Studies defining 
modulators of this process have largely concentrated on nutrients and peptides, but have traditionally 
neglected to investigate a role for the autonomic nervous system (ANS). It would seem beneficial for the 
brain to guide somatic stem cell proliferation via ANS signaling, therefore participating in decisions of 
tissue regeneration such as the replenishment of cells lost due to normal levels of apoptosis, renewal of 
tissues after injury, and growth of tissues during development or high nutrient availability. Roles for the 
ANS in controlling tissue regeneration have been identified after tissue injury in the liver (Cihak & 
Vaptzarova, 1973; Ashrif et al., 1974; Kato & Shimazu, 1983; Cruise et al., 1987) and pancreas (Medina 
et al., 2013), and following ANS nerve ablation in the intestine and adipose tissue (Tutton & Helme, 
1974; Musso et al., 1975b; Tsibulevskii & Orlova, 1976; Lachat & Goncalves, 1978; Kennedy et al., 
1983; Callaghan, 1991). However, the direct participation of ANS connections with the somatic stem 
cells in these effects has been overlooked. Investigation of a possible direct neural influence on somatic 
stem cell proliferation will allow for further understanding of the mechanisms regulating stem cells and 
may reveal neurally-driven strategies to therapeutically modulate somatic stem cell proliferation to treat 
tissue abnormalities. 
Limitations in studying the ANS effect on somatic stem cells 
Although studying the effect of the ANS on somatic stem cell proliferation is an attractive 
research topic, there are experimental barriers that have limited the progression of this field. For example, 
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although the ANS is known to participate in tissue regeneration after injury in the liver and pancreas 
(Cihak & Vaptzarova, 1973; Ashrif et al., 1974; Kato & Shimazu, 1983; Cruise et al., 1987; Medina et 
al., 2013), these tissues do not have identified stem cells that can be distinguished and/or isolated from 
other cell types within the tissue, eliminating the ability to study stem cell behavior in these phenomena. 
Studies investigating the effect of ANS nerve ablation on cell proliferation in vivo have also demonstrated 
a role for the ANS in tissue regeneration. These studies may have also identified indirect effects on 
proliferation due to post-surgical changes in food intake, inflammation, or other factors that can alter stem 
cell proliferation (Dailey, 2014; Slater et al., 2017). Furthermore, it appears that the regeneration process 
recovers after the initial loss of ANS input (Davis et al., 2017), likely due to adaptive mechanisms from 
other systems in vivo. These confounding variables of post-surgical side effects and eventual recovery 
mechanisms make it difficult to study the direct effect of the ANS on somatic stem cells in vivo. 
Therefore, a stem cell model that can be readily identified and isolated from its resident tissue and 
subsequently grown in vitro is necessary.  
Intestinal epithelial stem cells as a model to investigating ANS influence on somatic stem cells 
Intestinal epithelial stem cells (IESCs) are a suitable model to study ANS influence on somatic 
stem cell proliferation. Biomarkers on IESCs allow these cells to be identified and isolated for further 
study. IESCs can also be grown into intestinal epithelial organoids in vitro. An added advantage of using 
IESCs is that they undergo rapid proliferation, allowing for experimental measurement and manipulation 
in short periods of time. Further, the development of transgenic mouse models that express a green 
fluorescent protein (GFP) tag on an IESC biomarker adds to the relative ease of identifying and isolating 
IESCs from tissue using methods such as fluorescent activated cell sorting (FACS). Although ANS-
induced changes in somatic stem cell proliferation may not use the same mechanisms in all tissue types, 
investigation of this process in IESCs can develop the initial framework for the study of ANS influence 
on stem cells within other tissues.  
To regenerate intestinal epithelial tissue, IESCs divide to produce proliferating progenitor cells 
called transit-amplifying (TA) cells. These progenitor cells, in turn, differentiate into mature intestinal 
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epithelial cell types (e.g. enterocytes, goblet cells, enteroendocrine cells, and Paneth cells) as they migrate 
up the crypt-villus axis or to the crypt base. During differentiation, all of these mature cell types with the 
exception of the Paneth cells continue to migrate toward the tip of the villus in the small intestine or the 
surface epithelium in the large intestine, where they will undergo apoptosis. The apoptotic cells are then 
extruded into the lumen, and subsequently replaced by the new differentiated cells. By modulating the 
number and makeup of cells in the intestinal epithelium, putative ANS influence on IESCs may have the 
potential to influence intestinal epithelial functions such as nutrient absorption. 
Evidence in support of an autonomic influence on somatic stem cell proliferation: The intestinal 
epithelium 
The ANS participates regulating functions of the intestinal epithelium, the innermost layer of the 
intestinal mucosa. Examples include direct ANS modulation of functions such as fluid transport 
(Greenwood et al., 1987) and hormone release (Rocca & Brubaker, 1999). A growing body of anatomical 
and functional evidence suggests that the ANS can also directly modulate proliferation of the intestinal 
epithelial stem cells (IESCs) located within the crypts of the tissue. SNS nerve terminals are densely 
concentrated at the base of the crypt where the IESCs are located (Norberg, 1964; Gabella & Costa, 
1968), while PNS nerves make direct synaptic contact with intestinal epithelial cells (Bohorquez et al., 
2015). The SNS-associated alpha2A adrenoreceptor (α2A-AR) and the PNS-associated muscarinic 
acetylcholine receptor subtypes M1 and M3 are expressed in IESCs and have been functionally linked to 
a role in controlling proliferation in the intestinal epithelium (Paris et al., 1990; Valet et al., 1993; Schaak 
et al., 2000; Greig & Cowles, 2017a; Davis et al., 2018). Moreover, the primary autonomic 
neurotransmitters, norepinephrine (NE) and acetylcholine (ACh), are ligands of these receptors and are 
able to modulate IESC proliferation in vitro. Application of NE or ACh to intestinal epithelial organoids 
decreases expression of a key cell cycle gene, cyclin D1 (Davis et al., 2018), of which the protein is rate-
limiting in proliferation (Ohtsubo & Roberts, 1993; Quelle et al., 1993; Albanese et al., 1995; Watanabe 
et al., 1996; Resnitzky, 1997; Joyce et al., 1999). Consistent with these results, an ACh agonist decreases 
intestinal epithelial organoid proliferation (Takahashi et al., 2014). Together, these studies support a role 
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for ANS in the direct modulation of IESC proliferation and tissue regeneration through classically defined 
neurotransmitters and receptors. 
Denervation studies also support a role for the ANS in controlling IESC proliferation. Ablation of 
the SNS or PNS nerves innervating the intestine alters intestinal epithelial cell proliferation (Tutton & 
Helme, 1974; Musso et al., 1975b; Tsibulevskii & Orlova, 1976; Lachat & Goncalves, 1978; Kennedy et 
al., 1983; Callaghan, 1991). The effect may be due to the loss of the nerves as the in vivo source of 
autonomic neurotransmitters, which have been shown to alter proliferation in vitro. However, the 
experimental design of these studies did not allow changes in proliferation to determine if changes in 
proliferation could be specifically attributed to stem cells, TA cells, or a combination of both cell types. In 
addition, the results appear to be confounded by the time point investigated. After SNS denervation, 
proliferation increases at early time points (Lachat & Goncalves, 1978) and decreases at later time points 
(Tutton & Helme, 1974; Kennedy et al., 1983; Callaghan, 1991), with several studies demonstrating 
recovery to control levels of proliferation over time (Musso et al., 1975a; Lachat & Goncalves, 1978; 
Davis et al., 2017). The opposite effect is seen after PNS denervation, with proliferation decreased at 
early time points (Musso et al., 1975b; Lachat & Goncalves, 1978), increased at later time points 
(Tsibulevskii & Orlova, 1976; Callaghan, 1991) and eventually recovering (Musso et al., 1975b; Davis et 
al., 2017). The exact timing of recovery after SNS or PNS denervation seems to depend on the method of 
denervation used and which segment of intestine (duodenum, jejunum, ileum or colon) is investigated. As 
previously discussed, confounding factors may also be influencing these varying results across time 
points, including post-surgical changes in food intake or inflammation that are known to modulate 
intestinal epithelial cell proliferation (Dailey, 2014; Slater et al., 2017). Due to these limitations, 
denervation studies alone cannot be relied on to reveal clear trends in ANS influence on somatic stem cell 
proliferation under homeostatic conditions. Although these studies do provide valuable insight to this 
process in vivo, chronic loss of ANS input after denervation does not reflect the modus operandi of the 
ANS, which acts to rapidly modulate organ function under acute conditions. Despite these restrictions, 
these data demonstrate that there is likely a role of the ANS in intestinal epithelial turnover in vivo.  
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Based on the data outlined above, we propose models for the SNS and the PNS to directly 
influence IESC proliferation (Fig. 22). If either model were proven to be correct, it would be the first 
known instance of the nervous system directly regulating non-neuronal somatic stem cell proliferation.  
Possible effects of autonomic cotransmitters  
These models outline effects of NE and ACh, the primary autonomic neurotransmitters (Davis et 
al., 2018). However, autonomic cotransmitters are also possible candidates to bind to IESCs to effect 
changes in proliferation. The neuropeptide cotransmitters neuropeptide Y (NPY) and adenosine 
triphosphate (ATP) are coreleased with NE from sympathetic terminals (Burnstock, 2013), while ATP 
and vasoactive peptide (VIP) are coreleased from PNS terminals. All three of these autonomic 
cotransmitters modulate proliferation in different cell types. NPY alters proliferation of myofibroblastic 
hepatic stellate cells (Oben et al., 2003b), vascular smooth muscle cells (Erlinge et al., 1994), and 
preadipocytes (Tang et al., 2015). In vascular smooth muscle cells, NPY acts synergistically with NE to 
modulate proliferation (Oben et al., 2003b). ATP alters proliferation in vascular smooth muscle cells, and 
is additive to the effects of NE (Erlinge et al., 1993). VIP alters proliferation of hepatocytes (Kar et al., 
1996; Khedr et al., 2018), airway smooth muscle cells (Wang et al., 2018), and keratinocytes (Wollina et 
al., 1998). Based on these findings, there may also be a direct effect of NPY, ATP, VIP or other 
autonomic cotransmitters on IESC proliferation, possibly additively or synergistically with the classical 
neurotransmitters NE or ACh. Overall, investigation of the role of cotransmitters would allow further 
understanding of the complex mechanisms that the ANS might employ to influence proliferation of 
IESCs or somatic stem cells in other organs.  
Evidence for a role of the autonomic nervous system on IESC proliferation independent of the enteric 
nervous system 
The SNS and PNS make synaptic connections with neurons of the enteric nervous system (ENS), 
the intrinsic neural system of the gastrointestinal (GI) tract. The ENS is already known to participate in 
the control of intestinal epithelial cell proliferation (Zucoloto et al., 1988; Zucoloto et al., 1997; 
Hernandes et al., 2000) and, thus, can serve as a neural liaison to enact SNS- and PNS-driven functions.  
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Although the ENS is a possible pathway through which SNS and PNS alteration of IESC proliferation 
might occur, evidence indicates a role for the ANS to alter IESC proliferation independent of ENS 
participation. As NE is not an enteric neurotransmitter (McConalogue & Furness, 1994), the effect of NE 
on intestinal epithelial cell proliferation can only occur through SNS signaling, constituting a direct effect. 
With regard to the PNS, ACh is used by both the PNS and ENS as a neurotransmitter (McConalogue & 
Furness, 1994), which prohibits the definitive attribution of the effect of ACh on intestinal epithelial cell 
proliferation to the PNS or the ENS. However, as PNS denervation leaves ENS circuitry intact but still 
alters intestinal epithelial proliferation (Musso et al., 1975b; Tsibulevskii & Orlova, 1976; Lachat & 
Goncalves, 1978; Callaghan, 1991), this suggests a role for the PNS in controlling IESC proliferation, for 
which a direct effect cannot be ruled out.  
Autonomic influence on somatic stem cells: Potential applications for human medicine 
 ANS influence on somatic stem cells may be a valuable tool for applications in human medicine. 
Targeted manipulation of ANS outflow could be used to increase somatic stem cell proliferation and 
subsequently regenerate a variety of tissue types that are damaged or defective. For example, this strategy 
could be used on IESCs to treat short bowel syndrome, which is primarily characterized by a poor 
absorption of nutrients. Another approach could be used to drive somatic stem cell differentiation to 
purposely alter the ratio of mature cell types, in this case driving the cells toward an absorptive lineage. 
Notably, alteration of regeneration or differentiation may be an unintended side effect of ANS modulators 
currently used to treat other diseases. In addition to modifying tissue regeneration and differentiation, 
alteration of ANS-driven stem cell therapies might also be useful in the treatment of cancer. Many 
cancers are believed to be of stem cell origin, including the majority of colon cancers, which originate in 
IESCs (Barker et al., 2009). Therefore, ANS tone might be modulated to decrease the proliferation of 
cancer stem cells. Autonomic nerves innervate all solid tumors (39), and ANS denervation alters the 
growth of certain types of tumors in rodent models in vivo (Lackovicova et al., 2011; Zhao et al., 2014; 
Saloman et al., 2016; Decker et al., 2017). Some cancer cells also express autonomic neurotransmitter 
receptors and subsequently alter their proliferation in response to application of NE, ACh, or related 
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agonists/antagonists in vitro (Park & Cho, 2008; Liou et al., 2009; Huang et al., 2012; Ferretti et al., 
2013; Morelli et al., 2014; Coelho et al., 2015; Wang et al., 2016), an effect that is also seen in certain 
types of cancer stem cells (Alessandrini et al., 2015; Al-Wadei et al., 2016). Overall, these strategies to 
modulate stem cell proliferation could add to the current selection of ANS modulators in clinical practice.  
There is growing evidence that the ANS can alter somatic stem cell proliferation. 
Characterization of this understudied phenomenon would allow for better understanding of the complex 
interface between the nervous system and peripheral tissues, possibly allowing for the development of 
treatments involving neural manipulation of somatic stem cells for clinical use. 
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7.2 Figure and caption 
Figure 22
 
Figure 22. Proposed model of direct parasympathetic or sympathetic influence on intestinal 
epithelial stem cell proliferation.  
Parasympathetic model: 
When PNS activation occurs, preganglionic PNS neurons become activated. Cell bodies of these 
postganglionic PNS neurons are located in one of two areas: the dorsal motor nucleus of the vagus 
(DMV) in the brainstem, or the sacral spinal cord. From these regions, preganglionic PNS neurons project 
to the one of the two ganglionated plexuses of the enteric nervous system, the myenteric plexus or the 
submucosal plexus within the small intestine or colon. These neural projections travel via the vagus nerve 
(supplying the small intestine and proximal colon) or the pelvic splanchnic nerves (supplying the distal 
colon). Within the enteric plexus ganglia, these preganglionic PNS neurons make synaptic connections 
with postganglionic PNS neurons, which then project a short distance to make synaptic connections with 
IESCs. ACh released from the postganglionic PNS nerve terminals binds to M1 and/or M3 AChRs  
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Figure 22 (cont.) 
 
located on IESCs. This initiates an intracellular signaling cascade that causes a suppression of D1 
expression and a downstream decrease in proliferation. 
Sympathetic model: 
When SNS activation occurs, preganglionic SNS neurons become activated. Preganglionic SNS 
neurons have cell bodies located in the thoracic or lumbar spinal cord. These neurons project via 
splanchnic nerves to synapse onto postganglionic SNS neurons located in paravertebral sympathetic 
ganglia. The paravertebral ganglia include the celiac and superior mesenteric ganglia, which supply the 
small intestine, and the inferior mesenteric ganglion, which supplies the colon. Postganglionic SNS 
neurons then project to and make synaptic connections with IESCs. NE is released from the SNS nerve 
terminals and subsequently binds to α2A-ARs located on IESCs. Activation of the α2A-ARs by NE initiates 
an intracellular signaling cascade that causes a suppression of cyclin D1 expression and a consequential 
decrease in proliferation. 
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APPENDIX A: FURTHER INVESTIGATION OF THE VAGAL AFFERENT PATHWAY 
 
A.1 Rationale 
 
 After developing the methods necessary to isolate and test changes in vagal afferent nerves 
(presented in Chapter 2), I then began an investigation into the mechanisms underlying nutrient-induced 
vagal afferent neuroplasticity. I hypothesized that furin, a proprotein convertase that has been implicated 
in the control of neuroplasiticity in mammalian CNS neurons and peripheral neurons of other species, 
underlies nutrient-induced changes in vagal afferent fiber density at the level of GI tract and in the NTS. 
Although fiber density of the vagal afferents in the NTS and the levels of furin in the nodose ganglia 
(through immunohistochemistry and qPCR methods) were able to be assessed, I was unable to visualize 
the fiber density of the vagal afferent terminals in the GI tract using multiple methods (i.e., whole mount, 
CLARITY, frozen tissue on a cryostat, paraffin embedded on a microtome, gelatin embedded on a 
vibratome, muscularis peel). Because of this methodological issue, I did not pursue additional hypothesis-
driven studies. 
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A.2 Figures and captions 
Figure 23 
 
Figure 23. Evaluation of furin in the rat nodose ganglion. Representative image of immunohisto-
chemical localization of the furin protein in the rat nodose ganglion (Anti-Furin primary antibody, [1:50, 
ab183495, Abcam, San Francisco, CA], hematoxylin counterstain.) 
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Figure 24 
 
Figure 24. Visualization of vagal afferent neuron projections to the nucleus of the solitary tract. I 
traced vagal afferent neurons using biotinylated dextran amines injected into the nodose ganglion to the 
nucleus of the solitary tract. Tracer visualized with 3,3'-diaminobenzidine – horseradish peroxidase 
(DAB-HRP) immunohistochemistry.  
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APPENDIX B: EXCERPT FROM: OBESITY, INDEPENDENT OF DIET, DRIVES LASTING 
EFFECTS ON INTESTINAL EPITHELIAL STEM CELL PROLIFERATION IN MICE 
 
(Full manuscript published in Experimental Biology and Medicine; Citation: Zhou W, Davis EA, & 
Dailey MJ. (2018). Obesity, independent of diet, drives lasting effects on intestinal epithelial stem cell 
proliferation in mice. Experimental Biology and Medicine, 243(10), 826-835.) 
 
B.1 Abstract 
The intestinal epithelium plays an essential role in nutrient absorption, hormone release and 
barrier function. Maintenance of the epithelium is driven by continuous cell renewal by intestinal 
epithelial stem cells (IESCs) located in the intestinal crypts. Obesity affects this process and results in 
changes in the size and function of the tissue. Because both the amount of food intake and the 
composition of the diet are contributing factors to developing and maintaining obesity, it is necessary to 
tease apart the separate contributions of obesity versus the type/amount of diet in driving the epithelial 
changes. C57BL/6J mice were fed a 60% high-fat diet (HFD) versus a 10% low-fat diet (LFD) for 3 
months. A pair fed (PF) group was included (mice were fed with HFD, but in equal kcal as that eaten by 
the LFD fed mice to keep them lean). We investigated the differences in crypt-villus morphology and the 
number of differentiated epithelial cell types in vivo. We found that HFD-induced obesity, independent of 
the HFD, increased crypt depth, villus height, and the number of IESCs and goblet cells in vivo.  
B.2 Materials and methods 
Animals 
Male C57BL/6J mice at 10-weeks-old were obtained from the Jackson Laboratory (Bar Harbor, 
ME; N=24). Mice were individually housed in modified shoebox cages with a raised woven wire platform 
and lined with brown kraft paper for collection and measurement of food spillage. Mice were acclimated 
to the housing for 1 week with ad libitum access to tap water and laboratory chow (Tecklad 22/5, Tecklad 
Diets, Madison, WI) on a 12:12 light:dark cycle in a climate-controlled room (22 ± 1 °C and 60% relative 
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humidity). All procedures were approved by the Institutional Animal Care and Use Committee at the 
University of Illinois at Urbana-Champaign. 
Following the 1 week acclimation, mice were fed a HFD or a LFD for 3 months. The HFD and 
control groups were as follows: 1) 60% HFD ad libitum fed (Research Diets D12492), 2) 10% LFD ad 
libitum fed (Research Diets D12450J), and 3) 60% HFD PF group (fed a HFD, but in equal kcal as that 
eaten by the LFD fed animals to keep them lean), n=8 per group. It is not possible to include a LFD that 
eats the same kcal amount as the HFD ad libitum group without using a transgenic mouse or lesioning the 
hypothalamus to induce hyperphagia of the LFD. Mice were weighed weekly and food intake was 
measured daily. Mice in HFD PF group were given an equal kcal of the food eaten by the LFD fed mice a 
day later than other groups.   
After 3 months, mice were killed by decapitation under isoflurane anesthesia (Henry Schein 
Animal Health, Dublin, OH). A subset of the mice (n=5 per group) were used for histology. A power 
analysis (G*Power 3.1.9.2) based on previously published data investigating epithelial changes in 
vivo show that to achieve a power = 0.8 and a type I error of 0.05, an n=5 per group for in vivo analysis is 
needed (Mah et al., 2014; Beyaz et al., 2016). The intestine was exposed, and tissue was collected from 
the duodenum, jejunum, ileum and colon as previously described (Blackmore et al., 2017). Briefly, to 
ensure that we are collecting similar segments of the intestine for analysis between animals, we measured 
from the pyloric sphincter, discarded the first 1 cm and then collected two 5 mm samples to be processed 
for histology. We then measured from the cecum, discarded the first 1 cm and then collected two 5 mm 
segments of the ileum or colon. From the remaining jejunal segment, we measured from the middle and 
collected two 5 mm segments to be processed similarly to the duodenal and ileal segments. Each of the 5 
mm intestinal segments were fixed in 10% neutral buffered formalin for 24 h at RT and then stored in 
70% ETOH at RT prior to paraffin embedding.  
Formalin fixed tissue sections were embedded using paraffin and cut on a microtome at 5 µm 
thickness and mounted onto charged glass microscope slides. For crypt-villus morphology, tissue sections 
were deparaffinized in xylenes followed by a series of graded ethanol, then rinsed in deionized water. 
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Intestinal sections were counterstained in hematoxylin (Fisher HealthCare, Houston, TX) and dehydrated 
in a series of graded ethanol followed by xylenes. Slides were mounted with Permount mounting media 
(Fisher Scientific, Pittsburgh, PA) and stored at RT. 
For immunohistochemical processing for Olfactomedin-4 (Olmf4; an IESC marker) and 
Chromogranin A (an enteroendocrine cell marker), after deparaffinizing slides as described above, 
antigen retrieval was performed by immersing the slides in the sodium citrate buffer (10 mM sodium 
citrate hydrochloride [Fisher Scientific, Pittsburgh, PA] and 0.05% Tween 20 [Sigma- Aldrich, St. Louis, 
MO] diluted in distilled water, pH 6.0) for 20 min in a water bath at 95°C, then allowed to cool while still 
immersed in the sodium citrate buffer solution for 30 min at RT. Slides were rinsed between each step in 
1x PBS. Slides were incubated in blocking solution (3% Normal Donkey Serum [Jackson 
ImmunoResearch, West Grove, PA] and 0.3% Triton X-100 [Sigma-Aldrich, St. Louis, MO] diluted in 1x 
PBS) for 1 h at RT. Sections were incubated overnight at 4 °C in the following primary antibodies diluted 
in the blocking solution: Olmf4 (1:400; Cell Signaling Technology, Danvers, MA), Chromogranin A 
(1:1,000; Abcam, Cambridge, United Kingdom). Sections were incubated in a donkey anti-rabbit biotin-
conjugated IgG (H&L) secondary antibody (1:500, Jackson ImmunoResearch, West Grove, PA) diluted 
in 1x PBS for 1 h at RT. Sections were then incubated in an avidin-biotin complex (Vector Laboratories, 
Burlingame, CA) for 30 min at RT. A diaminobenzidine-hydrogen peroxidase reaction was performed 
using a substrate kit (Vector Laboratories, Burlingame, CA). Slides were dehydrated and mounted as 
described above.  
For Periodic Acid Schiff staining of mucins (a goblet cell marker) and Paneth cell granules (a 
Paneth cell marker), after deparaffinizing slides as described above, slides were immersed in 0.5% 
Periodic Acid (Newcomer Supply, Middleton, WI) for 10 min at RT and washed in distilled water. Sides 
were then immersed in Schiff reagent (Newcomer Supply, Middleton, WI) for 30 min at RT, and rinsed in 
0.55% potassium metabisulfite (Fisher Scientific, Pittsburgh, PA) for 30 sec and followed by washing in 
warm running tap water for 10 min. Slides were counterstained in hematoxylin, dehydrated and mounted 
as described above.  
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For staining of alkaline phosphatase (an enterocyte marker), after deparaffinizing slides as 
described above, slides were immersed in alkaline phosphatase substrate working solution (Vector 
Laboratories, Burlingame, CA) for 25 min. Slides were then washed in 100 mM Tris hydrochloride (PH 
8.2; Fisher Scientific, Pittsburgh, PA) for 5 min and followed by washing in running distilled water for 5 
min. Slides were dehydrated and mounted as described above.  
Intestinal tissues sections were visualized using a NanoZoomer Digital Pathology (NDP) System 
(Hamamatsu, Hamamatsu City, Japan) using a 40× objective and NDP Scan software. Crypt depth and 
villus height of 3 intestinal cross sections (4 crypts or villi per section) from each segment of the intestine 
(duodenum, jejunum, ileum and colon) per mouse were measured using NDP View 2 software. The 
number of Olmf4-postive IESCs, Chromogranin A-positive enteroendocrine cells, Periodic Acid Schiff-
positive goblet cells and Periodic Acid Schiff-positive Paneth cells of 3 intestinal cross sections (3 crypts 
or villi per section) from the jejunum per mouse were measured using NDP View 2 software. The 
expression of alkaline phosphatase was determined by measuring relative intensity of alkaline 
phosphatase staining of 3 intestinal cross sections (3 villi per section) from the jejunum per mouse were 
measured using ImageJ software. 
Data analysis 
Data are expressed as Mean ± SEM. For measurements of crypt depth, villus height, number of 
different intestinal cell types, and the relative intensity of alkaline phosphatase staining, differences 
between groups for each segment were analyzed using a one-way ANOVA. Fisher’s LSD post-hoc tests 
were used where appropriate. p<0.05 was considered statistically significant. 
B.3 Results 
Body weight and food intake 
 Body weight and food intake were increased in the HFD fed mice compared with the LFD and 
HFD PF groups  (Fig. 25A, B&C; p<0.05). 
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Intestinal crypt and villus morphometry 
 Crypt depth and villus height in the duodenum and jejunum were increased in the HFD fed mice 
compared with the LFD and HFD PF groups (Fig. 26B&C; p<0.05), but no differences were found in the 
ileum and colon (Fig. 26B&C). 
Number of intestinal epithelial cell types 
 The number of Olmf4-positive IESCs and Periodic Acid Schiff-positive goblet cells in the 
jejunum was increased in the HFD fed mice compared with the LFD and HFD PF groups (Fig. 27B&H; 
p<0.05). There were no differences in the number of Periodic Acid Schiff-positive Paneth cells and 
Chromogranin A-positive enteroendocrine cells in the jejunum between the HFD, HFD PF or LFD groups 
(Fig. 27D&F).  
Expression of intestinal enzymes or secretory proteins 
The protein levels of alkaline phosphatase (a marker for enterocytes) was highest in the HFD PF 
group in the jejunum (Fig. 28B; p<0.05). Specifically, alkaline phosphatase levels in the HFD PF group 
were increased compared with the HFD and LFD groups (Fig. 28B; p<0.05). Alkaline phosphatase levels 
were also increased in the HFD compared with the LFD group (Fig. 28B; p<0.05).  
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B.4 Figures and captions 
Figure 25 
 
Figure 25. Body weight (A), daily food intake (B) and average daily food intake (C) of mice fed with 
HFD or LFD for 3 months. Data are expressed as Mean ± SEM (n=8). * indicates significant different 
between HFD and HFD PF groups and between HFD and LFD groups at that time point, p<0.05. # 
indicates significantly different between HFD and LFD groups at that time point, p<0.05. 
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Figure 26
 
Figure 26. Representative images of hematoxylin stained crypt-villus morphology in the jejunum (A), and 
quantification of crypt depth and villus height in intestinal segments (duodenum, jejunum, ileum and 
colon) (B) collected from mice fed with HFD or LFD. Scale bar, 100 µm. Data are expressed as Mean ± 
SEM (n=5). Means with different letters indicate significantly different in each intestinal segment, p < 
0.05.  
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Figure 27 
 
Figure 27. Representative images of the jejunal sections stained with Olmf4 (IESC marker), Scale bar, 20 
µm (A), Paneth cell granules (Paneth cell marker), Scale bar, 20 µm (C), Chromogranin A 
(enteroendocrine cell maker), Scale bar, 100 µm (E), and mucins (goblet cell marker), Scale, 100 µm (G).  
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Figure 27 (cont.) 
 
Quantification of the number of Olmf4-positive IESCs (B), Periodic Acid Schiff-positive Paneth cells 
(D), Chromogranin A-positive enteroendocrine cells (F), and Periodic Acid Schiff-positive goblet cells 
(H) in the jejunum. Data are expressed as Mean ± SEM (n=5). Means with different letters indicate 
significantly different, p < 0.05. 
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Figure 28
 
Figure 28. Representative images of the jejunal sections stained with alkaline phosphatase (enterocyte 
marker), Scale bar, 100 µm (A), and quantification of relative intensity of alkaline phosphatase staining 
(B). Data are expressed as Mean ± SEM (n=5). Means with different letters indicate significantly 
different, p < 0.05. 
 
 
 
 
 
 
 
 
 
132	
	
B.5 References 
Beyaz S, Mana MD, Roper J, Kedrin D, Saadatpour A, Hong SJ, Bauer-Rowe KE, Xifaras ME, Akkad A, 
Arias E, Pinello L, Katz Y, Shinagare S, Abu-Remaileh M, Mihaylova MM, Lamming DW, 
Dogum R, Guo G, Bell GW, Selig M, Nielsen GP, Gupta N, Ferrone CR, Deshpande V, Yuan 
GC, Orkin SH, Sabatini DM & Yilmaz OH (2016). High-fat diet enhances stemness and 
tumorigenicity of intestinal progenitors. Nature 531, 53-58. 
 
Blackmore K, Zhou W & Dailey MJ (2017). LKB1-AMPK modulates nutrient-induced changes in the 
mode of division of intestinal epithelial crypt cells in mice. Exp Biol Med (Maywood) 242, 1490-
1498. 
 
Mah AT, Van Landeghem L, Gavin HE, Magness ST & Lund PK (2014). Impact of diet-induced obesity 
on intestinal stem cells: hyperproliferation but impaired intrinsic function that requires 
insulin/IGF1. Endocrinology 155, 3302-3314. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
133	
	
APPENDIX C: EXCERPT FROM: SEX DIFFERENCES INFLUENCE INTESTINAL 
EPITHELIAL STEM CELL PROLIFERATION INDEPENDENT OF OBESITY 
 
(Full manuscript published in Physiological Reports; Citation: Zhou W, Davis EA, Li K, Nowak RA, & 
Dailey MJ. (2018). Sex differences influence intestinal epithelial stem cell proliferation independent of 
obesity. Physiological reports, 6(13), e13746.) 
 
C1. Abstract 
 The intestinal epithelium is continuously regenerated by cell renewal of intestinal epithelial stem 
cells (IESCs) located in the intestinal crypts. Obesity affects this process and results in changes in the size 
and cellular make-up of the tissue, but it is unknown if there are sex differences in obesity-induced 
alterations in IESC differentiation. We fed male and female mice a 60% high-fat diet (HFD) or a 10% 
low-fat diet (LFD) for 3 months and investigated the differences in intestinal epithelial morphology in 
vivo.   
C2. Materials and methods 
 Male (n=24) and female (n=20) Lgr5-EGFP-ires-CreERT2 mice at 10- to 12-weeks-old were 
used. These mice were bred at the Division of Animal Resources facility at the University of Illinois at 
Urbana-Champaign from original breeding pairs obtained from the Jackson Laboratory (Bar Harbor, ME). 
Mice were individually housed in modified shoebox cages with a raised woven wire platform and lined 
with brown kraft paper for collection and measurement of food spillage. Mice were acclimated to the 
housing for 1 week with ad libitum access to tap water and laboratory chow (Teklad 22/5, Teklad Diets, 
Madison, WI) on a 12:12 light:dark cycle in a climate-controlled room (22 ± 1 °C and 60% relative 
humidity). All procedures were approved by the Institutional Animal Care and Use Committee at the 
University of Illinois at Urbana-Champaign. 
 Following 1 week acclimation, mice were fed a HFD or LFD for 3 months. Male and female mice 
were divided into groups based on average body weight as follows: 1) 60% HFD fed (Research Diets 
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D12492; n=13 males; n=11 females), and 2) 10% LFD fed (Research Diets D12450J; n=11 males; n=9 
females). After 3 months, mice were killed by decapitation under isoflurane anesthesia (Henry Schein 
Animal Health, Dublin, OH). The mice were killed in the middle of the light cycle following a 6 h food 
deprivation. A subset of mice (n = 6-10 per group) were used for histology. A power analysis (G*Power 
3.1.9.2) based on previously published data investigating the lasting effect of diet-induced obesity on 
epithelial changes in vivo show that to achieve a power = 0.8 and a type I error of 0.05, an n=5 per group 
for analysis is needed (Beyaz et al., 2016; Lee et al., 2018). To harvest tissue for histology, we exposed 
the intestine and collected the mid-small intestinal tissue (i.e., jejunum) as previously described 
(Blackmore et al., 2017). Briefly, to ensure that we were collecting similar segments of the intestine for 
analysis between animals, we measured from the pyloric sphincter and ileocecal valve to isolate the 
middle of jejunum and collected a 5 mm segment to be processed for histology. Each of the 5 mm 
intestinal segments were fixed in 10% neutral buffered formalin for 24 h at room temperature (RT) and 
then stored in 70% ethanol at RT prior to paraffin embedding.  
 Morphometric analyses were performed on formalin fixed, paraffin embedded, and hematoxylin 
stained cross sections. Briefly, intestinal sections (5 mm) were fixed in 10% neutral buffered formalin for 
24 h at RT and then stored in 70% ethanol at RT until later processing. In order to paraffin embed the 
tissue, sections were dehydrated in a series of graded ethanols, cleared in xylene and infiltrated with 
paraffin in a Tissue Tek VIP 1000 tissue processor (Miles, Elkhart, IN). Paraffin blocks of tissue were cut 
on a microtome at 5 µm thickness and mounted onto charged glass microscope slides. Tissue sections 
were then deparaffinized in xylenes, hydrated in a series of graded ethanols, and rinsed in deionized 
water. Sections were stained in hematoxylin (Fisher HealthCare, Houston, TX) followed by dehydration 
in a series of graded ethanols and cleared in xylene. Slides were coverslipped with Permount mounting 
media (Fisher Scientific, Fair Lawn, NJ). Intestinal tissue sections were visualized using a NanoZoomer 
Digital Pathology (NDP) System (Hamamatsu, Hamamatsu City, Japan) using a 40× objective and NDP 
Scan software. Nine crypts or villi from the jejunal sections per mouse were chosen based on intact 
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morphology of the intestine (Argenzio et al., 1990; Heise et al., 1991; Liu et al., 2015; Jinga et al., 2017). 
Crypt depth and villus height were measured using NDP View 2 software. 
 Data are expressed as Mean ± SEM. Differences between groups at each time point were 
analyzed using a two-way ANOVA. Fisher’s LSD post-hoc tests were used where appropriate. 
Assumptions of normality, homogeneity of variance, and independence were met. 
C.3 Results  
Intestinal crypt and villus morphometry 
 Crypt depth and villus height were greater in HFD fed mice than LFD group (Fig. 29A, B&C; 
p<0.05), but there was no sex effect or interaction between diet and sex (Fig. 29B, C). 
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C.4 Figure and caption 
Figure 29 
 
 
 
Figure 29. Representative image of hematoxylin stained crypt-villus morphology (A) and quantification 
of crypt depth (B) and villus height (C) in the jejunum collected from mice fed with HFD or LFD using 
diet and sex as two factors (two-way ANOVA). Data are expressed as Mean ± SEM (n=6-10). Scale bar, 
100 µm. 
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APPENDIX D: EXCERPT FROM: CENTRAL SENSORY-MOTOR CROSSTALK IN THE 
NEURAL GUT-BRAIN AXIS 
 
(Full manuscript submitted to Journal of Comparative Neurology. Citation: Parker CG, Davis EA, & 
Dailey MJ.) 
 
D.1 Abstract 
 The neural gut-brain axis consists of viscerosensory and autonomic motor neurons innervating the 
gastrointestinal (GI) tract. Sensory neurons transmit nutrient-related and non-nutrient-related information 
to the brain, while motor neurons regulate GI motility and secretion. Previous research provides an 
incomplete picture of the brain nuclei that are directly connected with the neural gut-brain axis, and no 
studies have thoroughly assessed sensory-motor overlap in those nuclei. Our goal in this study was to 
comprehensively characterize the central sensory and motor circuitry associated with the neural gut-brain 
axis linked to a segment of the small intestine. We injected a retrograde (pseudorabies; PRV) and 
anterograde (herpes simplex virus 1; HSV) transsynaptic viral tracer into the duodenal wall of adult male 
rats. Immunohistochemical processing revealed single- and double-labeled cells that were quantified per 
nucleus. We found that across nearly all brain regions assessed, PRV+HSV immunoreactive neurons 
comprised the greatest percentage of labeled cells compared with single-labeled PRV or HSV neurons. 
These results indicate that even though sensory and motor information can be processed by separate 
neuronal populations, there is neuroanatomical evidence of direct sensory-motor feedback in the neural 
gut-brain axis throughout the entire caudal-rostral extent of the brain. This is the first study to 
exhaustively investigate the sensory-motor organization of the neural gut-brain axis, and is a step toward 
phenotyping the many central neuronal populations involved in GI control. 
D.2 Materials and methods 
Parker CG performed all handling of animals, injections and tissue processing. I participated in 
data and statistical analysis.
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Data analysis 
 The entire caudal-rostral extent of the brain was analyzed for PRV and HSV immunoreactive 
neurons. For each section of each nuclei, the total number cells of each type (PRV+, HSV+, 
PRV+/HSV+) were counted. The average number of labeled cells of any type was calculated for each 
labeled nuclei across animals, and the percent of the total number of labeled cells in a given nuclei that 
were either PRV+, HSV+, or PRV+/HSV+ were calculated. One-way ANOVAs were performed to 
determine differences between groups. Assumptions of normality and homogeneity of variance were met.  
Data are presented as mean ± SEM.  
D.3 Results 
Across nearly all brain regions assessed, there was a majority of PRV+/HSV+ cells (Fig. 32b). 
Note that despite the consistent ratios of PRV+ or HSV+ to PRV+/HSV+ cells across nuclei, the actual 
number of neurons labeled in different brain nuclei varied greatly (Fig. 32a). Regions in the medulla and 
pons tended to have a greater percentage of HSV+ cells compared to PRV+ cells, while regions in the 
midbrain and forebrain tended to have a greater percentage of PRV+ cells compared to HSV+ cells (Fig. 
32b; see also Figs. 33-35). 
Hindbrain 
At the level of the hindbrain, there was labeling in a number of nuclei throughout both the 
medulla and pons. In the medulla (Fig. 33), labeling was prominent in the nucleus of the solitary tract 
(NTS), dorsal motor nucleus of the vagus (DMV), and the rostral ventrolateral reticular formation (RVL). 
This finding is consistent with the established functions of these nuclei, as the NTS receives first-order 
visceral sensory input via the afferent vagus nerve, the DMV contains preganglionic parasympathetic 
neurons and receives sensory relays from the NTS along with visceral spinal input, and the RVL 
innervates preganglionic sympathetic neurons in the intermediolateral cell column (IML). Labeling was 
also seen throughout the caudal raphe nuclei (e.g. RMg, ROb, RPa), which also send direct projections to 
the preganglionic sympathetic neurons. Labeled neurons were found in a number of other reticular nuclei 
as well. These nuclei are a relay for ascending pathways to the cortex in the ascending reticular activating 
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system and descending pathways to the spinal cord via the reticulospinal tracts. Both of these pathways 
are involved in multiple ANS functions. 
At the level of the pons, labeling was observed in a similarly wide variety of brain regions (Fig. 
32). Labeling continued to be observed in pontine reticular nuclei, including the specific noradrenergic 
cell groups NA5 and NA7, and the locus coeruleus (LC). The Barrington’s nucleus (Bar) and the 
parabrachial nucleus (PB) also showed labeling. Whereas the PB acts as an interface between medullary 
reflexes and forebrain action, the LC and Bar project to parasympathetic preganglionic neurons in the 
IML of the sacral spinal cord. 
Midbrain 
Midbrain labeling was observed in a more modest number of brain regions (Fig. 32). This again 
included a number of reticular nuclei, and also the dorsal raphe nucleus (DR) and the periaqueductal gray 
(PAG). The DR contains serotonergic neurons that innervate nuclei throughout the brain, including 
projections to the RVL in the hindbrain and many forebrain areas. The PAG, on the other hand, is known 
for its role in pain and receives peripheral information through the spinomesencephalic tract and sends 
descending information to multiple autonomic tracts. Labeling was also seen in the red nucleus (Red), 
which appeared to have a relatively higher percentage of single labeled PRV+ neurons than other labeled 
regions. Red is the origin of the rubrospinal tract and has multisynaptic projections to the cerebellum.  
Forebrain 
 Labeling in the forebrain was observed in a number of hypothalamic nuclei and limbic nuclei. 
Labeled hypothalamic nuclei included the paraventricular nucleus (PVN), lateral hypothalamus (LH), and 
dorsal hypothalamic area (DH; Fig. 33). Limbic brain regions labeled were the central amygdala (CeA), 
bed nucleus of the stria terminalis (BNST), and insular cortex (Ins; Fig. 34). 
D.4 Conclusions  
	 Although a number of studies have examined the broader communication network of 
viscerosensory and autonomic motor connections within the gut-brain axis [for review, see (Loewy & 
Spyer, 1990)], this is the first study to demonstrate the extent of sensory-motor overlap within the same 
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neurons at each node of the network. Roughly half of the gut-brain axis neurons at each nuclei in the 
central autonomic network include overlap of the sensory inputs and motor outputs, creating direct 
feedback loops. These direct feedback loops throughout the brainstem and forebrain have previously been 
described when outlining the viscerosensory and autonomic connections in other tissues [i.e. white and 
brown adipose tissue; (Ryu & Bartness, 2014; Ryu et al., 2015]. In fact, the neural circuits connected to 
white adipose tissue demonstrate the same ~50% overlap of sensory-motor neurons at each node of the 
autonomic network when using the same tracing methods as the present study (Ryu & Bartness, 2014). 
This suggests that the overlap in sensory-motor neuronal communication is not organ specific, but is a 
general characteristic of how the central viscerosensory and autonomic networks are organized. 
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D.5 Figures and captions 
Figure 30 
 
Figure 30. Total number of labeled cells (PRV+, HSV+, and PRV+/HSV+) per nuclei. Nuclei are 
arranged alphabetically in clusters corresponding to hindbrain, midbrain, hypothalamus, and other 
forebrain nuclei. Mean ± SEM. 
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Figure 31 
 
Figure 31. Percent of the total number of labeled cells per nuclei that were PRV+, HSV+, or 
PRV+/HSV+. Nuclei are arranged alphabetically in clusters corresponding to hindbrain, midbrain, 
hypothalamus, and other forebrain nuclei. Mean ± SEM. 
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Figure 32 
 
Figure 32. Viral tracer labeling in select brainstem nuclei. a) Representative image showing dense 
labeling in the AP. b) Representative image showing labeling in the NTS and DMV. c) Representative 
image showing labeling in the RVL. d) Relative proportions of PRV+, HSV+, and PRV+/HSV+ cells in 
select nuclei. Mean ± SEM. Scale bars indicate 100 um. 
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Figure 33 
 
Figure 33. Viral tracer labeling in select hypothalamic nuclei. a) Representative image showing 
labeling in the Arc. b) Representative image showing labeling in the LH. c) Representative image 
showing dense labeling in the PVH. d) Relative proportions of PRV+, HSV+, and PRV+/HSV+ cells in 
select nuclei. Mean ± SEM. Scale bars indicate 100 um. 
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Figure 34 
 
Figure 34. Viral tracer labeling in select forebrain nuclei. a) Representative image showing labeling in 
the BNST. b) Representative image showing labeling in the CeA. c) Representative image showing dense 
labeling in the Ins. d) Relative proportions of PRV+, HSV+, and PRV+/HSV+ cells in select nuclei. Mean 
± SEM. Scale bars indicate 100 um. 
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